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This work investigates partial body potassium determination in the human 
body using gamma-ray spectroscopy.  Potassium is an essential element in the human 
body that controls many of the enzyme systems and intra- and extra-cellular water 
flow.  Potassium is symptomatic to several disease cases and has gender and ethnic 
variability.  This work assesses the feasibility to measure partial body potassium in 
three specific regions: brain, arm, and leg, that are of interest to multiple sclerosis, 
chronic renal failure, and spinal cord injury, respectively.  Three detector systems 
were constructed and their capabilities assessed.  System characterization and 
analytical procedure for potassium evaluation and determination are presented 
together with experimental and initial clinical results.  The results indicate that partial 
body potassium measurement is viable, statistically reproducible, and has potential 
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The objective of this dissertation is to develop a technique to measure in 
vivo K content in the partial human body using gamma-ray spectroscopy and 
demonstrate the viability of the technique in determining regional PBK.  This 
proposed technique could have important clinical diagnostic significance and 
contribute to the characterization of response to various medications and therapy. 
 
Current Whole Body Composition Studies 
 
The main objective of body composition studies is to quantify the various 
components in the human body and to establish the steady-state relationships 
between them.  Relationships between and variations within a component 
occurring under various medical conditions (i.e., diabetes, malnutrition, HIV, 
obesity) or for various normal conditions (i.e., age, gender, ethnicity) are 
determined using in vivo (non- invasive) and in vitro (tissue chemical analysis) 
methods.1,2,3  Human body components, frequently redefined over the last 
hundred years, range from anatomical body segmentation down to atomic 
components.  The framework of the methodology used in body composition to 
compare various components was first recorded by Moore, through careful 
application of various dilution methods and the compilation of the results of the 
statistical analysis of these methods in hundreds of patient cases.4,5  Currently, 
repetitive clinical trials and comparisons with established body composition 
measures, are used to derive other component values that cannot be directly 





better understanding of the variations in the body components between the studied 
populations through continually improved forms of diagnostics. 2,7   
The earliest body composition model included two compartments; fat and 
fat- free mass.2  Currently, body composition divides the human body into over 30 
components, distributed among four or five main organizational levels.1,3,8  The 
five- level model, published in 1992, defines these levels as: 1) atomic, 2) 
molecular, 3) cellular, 4) tissue-system, and 5) whole body.2  A diagram, showing 
the main components present in each level, and their relative percentages by area 
is presented in Figure 1-1.2  The sum of the components at each level is equivalent 
to total body mass.1,2   
Modern whole body measurements include total body water (TBW) by 
tritium dilution; extracellular water (ECW) by non-radioactive bromine dilution; 
bone, fat and FFM by dual-energy x-ray absorptiometry (DXA); adipose tissue by 
magnetic resonance imaging (MRI); and total body potassium (TBK).  
(Substantive discussion of the methodology of these techniques can be found in 
Ellis (2000).6)  Other whole body measurements include body density and volume 
measurements using air or water displacement, body impendence using 
bioelectrical impedance analysis (BIA), and the measurement of total body O, C, 
H, N, Ca, P, Na, and Cl using in vivo nuclear methods such as inelastic neutron 
scattering, prompt gamma from thermal neutron capture, and neutron activation 
analysis (IVNAA).  IVNAA methods, however, require radiation doses and 
therefore are not widespread. 
Other compartments not mentioned above are derived, occasionally in 
multiple ways, such as intracellular water (ICW) from TBW and ECW, and 
independently from TBK.  Not all of the components indicated in Fig. 1-1 can be 
directly measured or accurately derived; an exception are the components at the 
atomic level, where all the major elements present in the human body can be 





listed in Table 1-1.2,8  This dissertation will focus specifically on determination of 
potassium in specific organs.   
The field of body composition studies has been gaining prominence in the 
last few years as the American public, physicians, and lawmakers have attempted 
to define, treat, and regulate the causes of obesity, which is reaching epidemic 
proportions in our society.  Body composition terms such as body mass index 
(BMI), fat- free mass (FFM), and skinfold measurement are starting to become 
familiar in everyday language as the focus turns back to the original nutritional 
and medical investigations of the composition of the body.  However, the question 

























Figure 1-1.  The five body composition levels of the human body with components. 


























Tissue- Organ Level 
 

































































O 61 Water, Protein, Glycogen 
C 23 Lipid, Fat, Adipose tissue, Skeletal Muscle 
H 10 Water, Carbohydrates, 
Proteins, Fats 
N 2.6 Protein 
Ca 1.4 Bone 
P 0.8 Bone, Lipid 
K 0.2 Intracellular Water, Skeletal Muscle 
Na 0.1 Extracellular Water 






Whole (Total) Body Potassium 
 
Potassium (K), an essential element and a key electrolyte in the human 
body, is important in regulating cellular membrane potential and cellular electrical 
function.  Dominantly present as an intracellular cation in all living tissue, and in 
conjunction with extracellular sodium, K regulates the cellular water balance and 
the acid-base balance.9,10  Potassium controls the sodium-potassium exchange 
across the cell membrane, and in neurons, inverses the membrane potential, 
generating muscle contractions, including cardiac function.10  Potassium also 
contributes to synthesis of protein, and glycogen and glucose metabolism in the 
human body.10 
In body composition studies, total body potassium has been related to 
body cell mass (BCM), a component developed to assess the quality of cell 
function in normal and ill subjects.  BCM is defined as the “oxygen-exchanging, 
potassium-rich, glucose-oxidizing, work performing tissue.”4  BCM was 
originally determined using total body exchangeable potassium (Ke), through a 
measurement of the exchange rate of an injected radioactive 42K tracer, providing 
a reasonable determination of BCM. 4,11,12  The 42K dilution method was replaced 
by the passive measurement of total body K (TBK) through detection of the 
naturally occurring 40K by using NaI(Tl) gamma ray spectroscopy detectors. The 
relationship between BCM and total body K, as measured from either Ke or TBK, 
remains constant for a healthy population and is estimated using Eq. 1-1 (no error 
bars given).4    
 
   .)(33.8)( mEqTBKgBCM ×=    (1-1) 
 
where 1 mEq. = 0.039 grams K.  In normal adult subjects, TBK is reported to 
have a very high precision (0.8%) and a high accuracy in measuring whole body 





through longitudinal and cross sectional studies (discussed further in next 
section), and used to infer variations in cohort BCM. 9,13,14  However, it should be 
noted that TBK measurement provides an average value of the potassium content 
in the entire body. 
TBK has also been used to determine the fat- free mass component (FFM) 
of the two compartment model, using whole body chemical analysis of 
cadavers.13,14,15  FFM includes the BCM, extracellular fluids and tissues and 
skeletal bone, which contain negligible amounts of K.  From FFM, the TBK/FFM 
ratio has been applied as a reference standard to estimate body fat (Eq. 1-2), and 
an estimate of skeletal muscle mass (SM).13  For normal subjects, the  TBK/FFM 
ratio is considered constant at 68.1 ± 3.1 mmol/kg, with wide variations from age 
and sex.13  The estimate of SM relies on the assumption that 49% of FFM is SM.13   
 
















)(    (1-2) 
 
 
A determination of SM from TBK alone has also been recently determined for 
healthy individuals, with a prediction equation available for co-variates such as 
age, sex, and race (Eq. 1-3, no error bars given).16 
 
)(0085.0)( mmolTBKkgSM ×=    (1-3) 
  
where 1 mmol K+ = 0.039 grams K. 
A standard 70 kg person, contains 140 gK, 98% of which is in the 





of normal subjects, Ke, total exchangeable sodium (Nae), and the sum of Ke and 
Nae have been shown to be highly correlated with ICW, ECW, and total body 
water (TBW), respectively (ICW, ECW: r = 0.98, p<0.01; TBW: r = 0.99, 
p<0.01).4  When TBW is held constant, ICW and ECW have been shown to be 
highly inversely correlated, to a very high significance level.4  A lower 
ICW/TBW ratio in a subject is indicative of disease, regardless of associated 
increase in absolute value of ECW.  The extremely close relationship between Ke 
and ICW has been extended to apply to TBK and ICW.4  Therefore, the 
relationship of BCM and TBK (Eq. 1-1) is derived from the relationship between 




BCM =      (1-4) 
 







ICW ×=     (1-5) 
 
where 1 mEq. K+ = 1 mmol K+ = 0.0039 grams K.4 
The relationship between BCM, FFM, SM, and ICW were derived for the 
whole body, however, there is a strong interest to establish these relationships in 
specific organs as they pertain to specific diseases.  In the past, variations in the 
TBK were related to some chronic diseases, or abnormal conditions.  In order to 
gain sensitivity or specificity to changes, these rela tionships might be sought in 
specific organs.  The amounts of K encountered in specific noteworthy sites is 
smaller than in the whole body.  While a standard 70 kg man contains 140 gK, the 
organs investigated in this work contain the following gK: 1) normal brain (male), 





and 3) normal leg, 20-25 gK.17  The amount of gK in the arm and leg are 
estimated from the amount of gK present in the muscle mass in the extremities, 
reported from Reference Man,17 and divided into a 2/5 ratio for the arms estimate, 
and 3/5 for the legs estimate.  Dividing by two to extrapolate to a single arm or 
leg, this estimate is reported as a range to represent the variability of human 
weight and build. 
 
Variation in TBK Measurement 
 
TBK has been measured for the past 30 years.  Several longitudinal and 
cross-sectional studies have been reported from a variety of TBK system 
configurations, including shadow-shield, 2p and 4p counters.  These studies show 
that total body K changes over age, differs by sex, and is generally lost by disease 
conditions.  Within a given subject measure, reported physiological and 
instrumentation (systematic) variations in an individual measurement are 
extremely small (0.5-1%), and for a given subject over short-term and long-term 
instrument stability, the systematic variation is likewise small (standard deviation 
about the mean of 1.2-4.8%).9,14  In normal subjects, TBK physiologically varies 
as a function over time, progressively gaining until 30 years of age for males (25 
years for females), with a gradual decline as the subject ages (subjects measured 
up to 85 years of age).14  Some reported physiological variations for various 
cohorts measured by TBK are listed in Table 1-2. 
TBK systems have been calibrated using a variety of techniques including, 
water/tissue equivalent phantom calibration measurements, comparison with 42K 
(injected) tracer studies in human subjects, and comparisons with post-mortem 
cadaver studies.6,14  For large TBK counters (40-60 detectors), the TBK counter 
has been shown to have very little response to variations due to geometric 





gamma ray absorption are determined using standard calibration techniques, in 
addition to calibration radionuclide sources (such as 137Cs and 60Co) and computer 
modeling of the anticipated absorption.  14,18  For example, for a 54 detector TBK 
counter at BNL, systematic error in the calibration using 42K for normal, non-
obese subjects was ~3%.11,14  Computer modeling and phantom measurements are 





Table 1-2.  Reported physiological variation and statistical uncertainty 
in TBK measurement by cohorts.9,14,19 
 











Adult Normal Male 
(Shukla, et al.) 
1 yr. 7 12 5.2%  2.5%  
Adult Normal Female 
(Shukla, et al.) 
1 yr. 3 12 5.6%  2.5%  
Adult Normal Male 
(Shukla, et al.) 
Multiple daily, for 10 
days 
4 10-15 0.5%  2.5%  
Adult Normal Female 
(Shukla, et al.) 
Multiple daily, for 10 
days 
2 11-15 1%  2.5%  
Adult Normal Male 
(Maletskos and Osborne) 
2 mo. N/A 6-8 4-7%  2-3%  
Adult Normal Male 
(Johny, et al.) 
N/A 12 N/A 1.2%  4%  
Adolescenta Normal Maleb 
(Pierson, et al.) 
15 yrs. 1782 N/A 3%  1.2-4.8% c 
Childd Normal Male 
(Novak, et al.) 
1 day/subject 19 2 10%  1.5%  





Necessity of Partial Body Composition and Partial Body K 
 
As body composition studies derive additional components, at greater 
levels of accuracy, the measurements are limited to the whole body or system 
level.  However, regional body component measurements offer more specificity 
and sensitivity.  In many cases, the single organ is affected and involves changes 
in K.  Clearly, measuring total body K would dilute and potentially mask the 
change that occurred in a single organ.  Thus, under conditions affecting only 
specific organs, a partial body measure could potentially measure the component 
change in the organ.  Partial body measurement could also be used in conjunction 
with whole body measure to identify the region of change, in diseases or 
conditions where the component organ of change is unknown.  Furthermore, 
partial body measure could also be used as a less expensive alternative to whole 
body measure, in monitoring effectiveness of medication, exercise, or other 
treatment therapies.  Partial body measure is potentially less expensive, more 
flexible, and mobile.  
Passive measurement of K is easily adaptive to partial body potassium 
(PBK) measurement.  Special attention has to be paid to the ever present high 
concentration of potassium in the background, and to discern the human body K 
contributions from regions outside the region of interest.   
Variations in regional potassium are potentially very small, on the order of 
5% or less.  For small regions of interest, such as the brain, the change in K is in 
tenths of gK.  Reduction of the background K, and increasing the K signal-to-
noise ratio would be essential to increase the likelihood of observing the variation 
in K.  A successful PBK measure would provide information on regional K, and 
change in the regional K.  Through the relationship of K with other components, 





proportionately changing regional BCM, ICW, FFM, and SM.  By addressing the 
constraints, in vivo partial body potassium measure is achievable. 
This dissertation addresses the constraints and specific mechanisms for 
measuring partial body potassium applications with the results discussed from 
initial calibrations, initial subject studies, and improvements in statistical error 
reduction and sensitivity.  Three separate regions were investigated and the 
rational for the three specific PBK applications is addressed in the following 





1.1. Potential Clinical Applications  
 
Three potential applications of PBK in the brain and in the limbs were 
investigated in this dissertation in connection with 1) multiple sclerosis, 2) 
chronic renal failure and sarcopenia, and 3) spinal cord injury, respectively.  
These three sites require different detector-shielding configurations to isolate the 
sought K signal emitted from the organ of interest from those originating from 
other parts of the body and from the general background.  Specifically, the three 
different systems were calibrated for brain, lower and part of upper arm, and thigh 
with part of upper calf, and are identified as BNL system for brain measurement, 
SLR system for arm measurement, and BVA system for leg measurements in SCI 




Multiple Sclerosis (MS), a major acquired neurologic disease of young 
adults, is characterized by the demyelinization of nerve cells (lesion) which 
inflicts paresthesias, visual impairment, and motor and cerebellar abnormalities, 
resulting in severe morbidity of the involuntary muscles.20,21,22  Axons, and 
possibly neuronsoma are affected in MS, with a subset of patients diagnosed with 
“targeted disruption” of the oligodendrocytes.23  A progressive degenerative 
disease, the earliest detectable change in MS is central nervous system (CNS) 
edema and inflammation. 24  High edema content regions are the most susceptible 
to MS lesion development, though lesion development as tracked by MRI is not 
entirely coincidal with symptomatic disease onset.20,25,26,27  Edema reflects new 
disease activity, and a method to characterize the unknown proportion of 
intracellular water to extracellular water in the edema would provide new insights 





In the normal brain, the brain tissue is composed of three spaces, vascular, 
interstitial, and intracellular.  Water comprises 80% of the brain, with 20% of all 
water content present in the extracellular spaces.  In the human body, the most 
abundant aqueous cations are potassium and sodium, distributed asymmetrically 
across the cell membrane.  Potassium concentrations within the intracellular space 
are at a level of 30 to 40 mmol, while sodium is concentrated in the extracellular 
space.  In MS, edema may increase the total brain water content by up to 5%, but 
the proportion of intracellular (cytotoxic) to extracellular (vasogenic) edema is not 
possible to assess at present.20  However, an increase in the intracellular water 
content should correspond to concurrent increase in K content to maintain cell 
membrane potential, assuming that the K concentration remains at normal 
intracellular levels. 
Thus, the working hypothesis for the partial body K measurement in the 
brain is that an increase in ICW would correspond with a concurrent increase in 
K.  This change in K, if measurable, will be normalized by the total brain water 
volume as measured by MRI.  No change in this ratio would suggest concurrent 
increase in volume and K indicative of cytotoxic edema.  However, a decrease in 
this ratio would suggest vasogenic edema.  In this hypothesis, it is assumed that 
the cellular K concentration remains constant. 
A basic system to measure K in brain has been constructed at Brookhaven 
National Laboratory (BNL) in Upton, NY.   
 
Chronic Renal Failure  
 
Chronic renal failure (CRF), a condition affecting young people and 
adults, is caused by many factors including high blood pressure, high cholesterol, 
heart disease, liver disease, kidney disease, and other illnesses and some long-





capacity, leading to severe morbidity and mortality. 28  Hemodialysis is the 
recommended treatment for severe cases of CRF.  Physically, severe CRF 
contributes to an observable decrease in muscle mass, the mechanism of which is 
not fully understood.29,30  Insight into the mechanisms of protein loss in CRF, 
whether from a loss of visceral (trunk/organ) protein or from skeletal (limb) 
protein would provide information for potential drug therapies.30  Furthermore, 
other factors such as sarcopenia, and decreased physical activity from aging affect 
muscle mass loss similarly and a method to differentiate between the different 
causes of muscle loss in CRF patients is also sought.30   
The relationship between TBK and BCM has been characterized (Eq. 1-1), 
and clinically has been used to represent changes in total lean muscle tissue 
caused by disease or recovery treatment.4  A partial body potassium measurement 
in the arm muscles may contribute to a more accurate assessment of wasting, by 
eliminating the trunk organ body potassium contribution as a diluting factor to the 
lean muscle mass.31 
Analytical determination of partial body K in the human arm, from 
hemodialysis, elderly and normal volunteers participating in initial clinical trials 
of arm PBK at St. Luke’s Hospital in New York was evaluated, and statistical 
analysis was applied to determine the correlation of arm PBK to standard whole 




Sarcopenia is defined as the non-pathological loss of skeletal muscle mass 
(SM) in the elderly, through decrease in quantity and strength.16  Although SM 
comprises nearly one-half of FFM, and is represented by 60% of TBK in 
reference man, the estimate of FFM from TBK incorrectly assumes the TBK/FFM 





ratio also varies with both age and sex, where specifically, in elderly subjects, a 
lower TBK/FFM ratio and corresponding lower TBK/SM ratio has been 
observed.14,33  The observed reduction in the TBK/SM ratio in the elderly is due 
to an increase in body interstitial adipose tissue combined with skeletal mass 
atrophy.32   Both of these mechanisms could lead to a reduction of the amount of 
potassium-rich myofiber muscle mass in the body, and contribute to a relative 
increase of nominal potassium connective adipocyte- laden tissue (i.e., adipose 
tissue) and extracellular fluid (ECF).33,34  A more accurate method to differentiate 
between these two SM loss mechanisms is sought.  The measurement of partial 
body K in the arms, which would measure potassium-rich muscle mass change, 
provides an assessment of SM without concurrently measuring the potassium-
poor adipose tissue change.  PBK analysis in the arms of hemodialysis, elderly, 
and normal subjects, provides a comparison of potassium measures as a first step 
towards addressing the difference in muscle mass between these cohorts.  
 
Paraplegia and Tetraplegia 
 
Spinal cord injuries (SCI), resulting in paraplegia and tetraplegia, are 
characterized by severe trauma to the spinal canal nerves through injury or 
disease.35  In severe forms of SCI, sudden, acute immobilization of the patient 
occurs and rapid muscle atrophy is physically observed below the site of injury 
(i.e., lesion).36,37  Two stages of muscle atrophy have been identified, the initial 
acute phase of immobilization and post-acute phase.  Post-acute phase (over 1 
year post- injury) has been well characterized by BCM, TBW, and ICW, which 
have been observed to decrease accordingly with increased time and severity of 
the injury. 38  Furthermore, recent studies have shown that after the initial acute 





relationship exists between the loss of leg lean tissue and the duration of time 
after injury (3 to 26 years post- injury).39     
The challenge, however, is to characterize the rapid muscle loss and the 
response to various medications and therapy, within the initial acute phase of 
immobilization (0 to 1 month).37  The earliest studies have captured muscle 
atrophy at 14-15 weeks post injury, when the majority of atrophy has already 
occurred.40,41  A method to monitor muscle mass atrophy during the initial acute 
phase, in newly SCI patients is presented.  The method is implemented at the 
patient bedside with minimal movement of the immobilized patient. 
The system for measuring PBK in leg is being developed at BNL and will 





2.  Hypothesis   
 
The determination of in vivo partial body potassium measurement using 
40K gamma ray spectroscopy techniques is feasible when the following 
assumptions are addressed: 
 
1) The naturally occurring K in the human body can be determined from 
the solitary radioactive naturally occurring isotope of K, 40K, since 40K 
is long lived, and therefore is in relatively steady equilibrium with the 
remaining two naturally occurring non-radioactive isotopes of K.  
(Chapter 2.1.1.) 
 
2) Naturally occurring K in the ambient room background can be 
assessed, characterized, and minimized.  (Chapters 2.1.4 and 3.4.) 
 
3) External body K, defined as K outside of the organ region of interest, 
can be characterized and minimized through optimized system 
geometry.  (Chapters 2.1.4 and 3.4.)  
 
4) Gamma ray spectroscopy (detection) of 40K is through the three 
primary interactions of gamma rays with matter, and standard 
photopeak energy calibration techniques can be applied.  (Chapters 
2.1.2, 2.1.3 and 3.3.1.) 
 
5) Due to the low count rates from the low concentrations of K in the 
organ/regional K regions of interest (ROI), non- linear effects were not 
present in the gamma ray energy spectra measured using NaI(Tl) or 





content through the detection of 40K was linear with concentration.  
(Chapters 2.2.1 and 3.3.2.) 
 
6) Concentrations of Organ or Regional K (i.e., PBK) in the human body 
can be extrapolated from phantom calibrations.  (Chapter 3.) 
 
7) Complex factors contributing or interfering with measurement of 
Regional K can be addressed with region-specific phantoms and point 
source calibrations.  (Chapter 4.) 
 
8) Standard analytical techniques for the evaluation of K from gamma ray 
spectra can be applied and assessed for effectiveness in minimizing 
statistical error propagation.  (Chapters 2.2 and 5.) 
 
9) Organ or Regional K (i.e., PBK) with its associated uncertainty can be 
determined and compared with related standard whole body 




There are three major limitations to the hypothesis: 
 
1) Regional K (PBK) will contribute a small K signal to be measured 
since small amounts of K are present in each region of interest and the 
percent abundance of 40K is extremely small (0.0112%) relative to 






2) Naturally occurring ambient (room) background K is omnipresent 
from structural and external body K.  (Chapter 2.1.4.) 
 
3) The 40K measurement counting time is limited to maintain subject 
comfort during the measurement.  (Chapter 3.) 
 
Limitations 1, 2, and 3 contribute to a low counting statistics condition in this 
project which can be addressed through: 
 
A) Maximizing the sensitivity of the detection system.  (Chapters 2.4 and 
4.2.) 
 
B) Minimizing the naturally occurring omnipresent background K 
through shielding considerations.  (Chapter 3.4.) 
 
Additional Considerations  
 
Resolving the K concentration of a sample from a gamma ray spectrum with 
highest precision and accuracy requires: 
  
A) Accurate characterization of system configuration using region-
specific phantoms.  (Chapter 4.) 
B) Minimizing statistical error propagation.  Two numerical analysis 
methods, Trapezoidal Method (TM) and Library Least Squares 
Method (LLS), are evaluated and compared for lowest statistical error 







2.1. Key Terminology: Physics 
 
2.1.1. Physical Characteristics of K 
 
Potassium is naturally distributed in three isotopic states: 39K, 41K, and 40K 
at 93.3%, 6.7%, and 0.0112% relative abundance, respectively.42  Radioactive 
isotope 40K, because of its extremely long half- life of 1.28 X 109 y is relatively 
constant for the period of this study with stable 39K and 41K, and therefore 
physical decay corrections are not needed.43,44  40K decays by two different 
transmutations, 1) electron capture to stable 40Ar with a subsequent, solitary 1.46 
MeV gamma ray emitted (occurring 10.7% per disintegration), and 2) beta decay 
(ß-) to stable 40Ca with a maximum beta energy of 1.31 MeV for 99% of beta 
decays (with an occurrence of 89.3% per disintegration). The decay schemes are 
shown in Figs. 2.1.1-1 and 2.1.1-2. 
The activity of 40K, A, in disintegrations per minute (dpm) is given by Eq. 
2.1.1-1, 
 
NA λ=     (2.1.1-1) 
 
where λ is the decay constant and N the number of radioactive 40K atoms.45  From 
the nuclear characteristics of 40K, there are 1.8 X 103 dpm/gK, which yields 198 
gammas per minute per gram of natural K.44,46  From 40K in assumed fixed 
relative abundance with stable K, obtaining a measurement of the 1.46 MeV 
gamma ray from 40K provides a direct measure of the amount of total K present in 
a measured sample volume.  Therefore, Reference Man17 produces approximately 
28,000 gammas per minute from 40K decay for the whole body, while reference 
woman produces approximately 24000 gammas per minute fo r the whole body 





body, the regions of interest in this project will approximately produce the 
following amounts of gamma per minute 1) brain, 850 gamma per minute, 2) arm, 
















Figure 2.1.1-1.  Decay scheme of 40K by electron capture. 





























Figure 2.1.1-2.  Decay scheme for 40K by beta decay. 
















2.1.2. Gamma Ray Spectroscopy: Interaction of Gamma Rays with 
Matter47,48,49 
 
There are five main types of x-ray and gamma-ray interactions with 
matter: 1) photoelectric effect, 2) pair production, 3) Compton effect, 4) Rayleigh 
(coherent) scattering, and 5) photonuclear interactions.  Of these, the primary 
modes of interaction in gamma ray spectroscopy are the first three.  These three 
processes contribute to the transfer of gamma ray photon energy to atomic 
electrons or nuclei, resulting in the complete or partial transfer of gamma ray 




The photoelectric effect is an absorption process, where a photon is 
completely absorbed by an atom, and an energetic photoelectron with energy Epe 
(Eq. 2.1.2-1), is ejected from the bound shells.  Three key aspects of this 
interaction: 1) it occurs only with atoms, not free electrons, 2) the most probable 
interaction is with the tightest bound K electron shell, and 3) it occurs as the 
predominant interaction for photons of low energy, and the probability of 
interaction increases with high atomic number Z materials.  The photoelectron 
energy is written as 
 
bpe EhE −= ν     (2.1.2-1) 
 
where hv is the incident photon energy and Eb the binding energy of the bound 
atomic electron.  The filling of the empty K shell, with electrons from higher 
shells, produces associated x-rays, in conjunction with this process.  The mass 










A scattering interaction, Compton scattering also occurs between an 
incoming photon and an atomic electron.  However, in this interaction, the 
incoming photon deflects at some angle from the electron, and the energy lost 
during the scattering, is transferred to the recoiling electron, which is initially 
assumed to be unbound and at relative rest.  (The difference in calculated energy 
from interaction with a non-resting, bound electron is customarily considered 
negligible for radiological physics purposes.)  The equation for the energy of the 













   (2.1.2-2) 
 
where moc2 is the electron rest-mass energy (0.511 MeV), and ? the angle of the 
scattered photon (Fig. 2.1.2-1).  The energy transferred to the electron varies from 
near zero (for ? ≅ 0) to a significant fraction of the incident gamma ray energy 
(for ? = p).  This interaction occurs dominantly for mid-energy photons, low 
energy photons with very low Z materials (less than Z = 5), and high energy 
photons with very low Z materials.  The mass attenuation for Compton scattering  








Figure 2.1.2-1.  Schematic of Compton scattering interaction.  (Modified 
















Pair production is another absorptive process, in which a photon greater 
than 1.022 MeV (2moc2) interacts with the coulomb field of a nucleus and 
transforms into an electron-positron pair with energies of 0.511 MeV each.  This 
process cannot occur with a photon energy less than 1.022 MeV, since this is the 
minimum binding energy required for the interaction.  The remaining energy 
above 1.022 MeV of the incident photon is transferred as kinetic energy, split 
between the electron and positron.  This interaction occurs for high energy 
photons only, and the magnitude of the interaction can be approximated by the 
square of the absorber atomic number Z.  The equation for the conservation of 
energy of the system is 
 
+− ++= TTcmh o
22ν    (2.1.2-3) 
 
where hv is the incident photon energy, 2moc2 the rest-mass energy of the electron 
and positron, T- the kinetic energy of the electron, and T+ the kinetic energy of the 
positron.  The relatively infinitesimally small recoil energy of the nucleus is 










   (2.1.2-4) 
 
where hv is the incident photon energy.  The mass attenuation coefficient for pair 






2.1.3.  Gamma Ray Spectroscopy: Scintillator Response Functions  
 
Effects of Surrounding Materials on Response Function48,49 
 
Any materials which encapsulate the radiation source or the scintillator 
detector can have an influence on the radiation the detector receives.  For this 
project, some of the materials include: 1) the aluminum encasing surrounding a 
NaI(Tl) detector, lightpipe, and photomultiplier tube, 2) the lead shielding 
surrounding the detector to reduce natural ambient room background, and 3) the 
tissue or phantom-equivalent material surrounding the potassium.  The photons, 
from the K source or the ambient background, interact with the materials 
primarily through the photoelectric effect, Compton scattering, and pair 
production as discussed in Chapter 2.1.2.   The interactions of the photons from 
the source or ambient background with the materials produces secondary 
radiations which influences the shape of the detector response function. 
The three secondary radiations produced are: 1) backscatter gamma rays, 
2) characteristic x-rays, and 3) annihilation radiation.  Backscatter gamma rays 
are caused by photon interactions with the material through Compton scattering.  










==    (2.1.3-1) 
 
and for incident photons greater than moc2/2, Eq. 2.1.3-1 reduces to 
 






such that backscatter peak energy is less than 250 keV.  Interactions of photons 
with material through the photoelectric effect, creates x-rays with specific 
energies, based on the atomic number Z of the material, called characteristic x-
rays.  Lead, for example, has characteristic x-rays between 50-70 keV.  When the 
incident photon has high energy (greater than 1.022 MeV), such as highly 
energetic naturally occurring cosmic rays, pair  production is the primary mode of 
interaction.  The re-absorption of the electrons and positrons produced, within the 
material, produces the annihilation radiation, that in sufficient quantity, can be 
seen above the Compton continuum.  An approximate example of the response 
function of a 3”x3” NaI(Tl) detector for 40K is shown in Figure 2.1.3-1, with the 
three secondary radiations labeled.  More extensive and well-defined detector 
response functions with high-precision calibration sources, and for specific sized 
NaI(Tl), are available from commercial manufactures and are also detailed by 
Mueller and Maeder,51 Heath,52 and Adams and Dams 53.48  Other observable 
peaks above the Compton continuum can be also caused by summation effects as 










Figure 2.1.3-1.  Example of NaI(Tl) response function for K photopeak.  







2.1.4.  Definition of Naturally Occurring Ambient Background 
 
Characterization of Contributions to Ambient (Room) Background 
 
The omnipresence of natural K in the ambient (room) background makes 
its reduction critically important for PBK analysis.  Thus, reduction of the 
background will first of all, reduce the contribution to the K photopeak due to 
environmental K, resulting in improved signal-to-noise ratio and reduction in the 
statistical error propagation in the analysis of PBK.  Various features of a typical 
background spectrum acquired over 72 hours using a NaI(Tl) detector are shown 
in Fig. 2.1.4-1.  Several of the features in the spectrum, where possible, are 
identified in Fig. 2.1.4-1.  These sources, not necessarily in order of importance, 
are listed below: 
 
1) Cosmic background - It is, in general, a continuum of multiple scattered 
gamma radiation created in, and arriving from, the atmosphere and 
shielding materials.  The only mechanism of partial reduction is by 
shielding of the detectors and Compton suppression. 
 
2) Environmental radioisotopes - There are three omnipresent dominant 
radionuclides in the background namely thorium (Th), potassium (K), and 
rubidium (Rb).53  Additional radionuclides in equilibrium in the 
environment are of much lesser importance, and include radionuclides 
from the decay of the uranium, thorium, and actinium series, such as Ra-
222, and non-series radionuclides such as K-40 and Rb-87.54  The Bi-210 






3) Photo Multiplier Tube (PMT) - PMTs contain radioactive K in their 
structural materials, in particular in the glass.  Thus, for a given detection 
system, their contribution to the K photopeak is constant.  Selecting low 
potassium background tubes that use quartz instead of the regular glass 
can reduce this contribution. 
 
4) Human body - During PBK measurements there is always a risk that some 
other parts of the human body unrelated to the region of interest may 
contribute to the PBK reading.  This can be eliminated or at least reduced 
by proper shielding and collimation of the detection system from the rest 




















Fig 2.1.4-1.  A typical background spectrum acquired for 72 hours. 
 Various contributing components to the background are  
identified in the graph.  The K photopeak region of interest (ROI) is 
indicated, with the background (Bckg) from the Compton contributions 






2.2.  Key Terminology: Analytical Methods  
 
2.2.1.  Trapezoidal Method and Associated Statistical Error48,55,56,57 
 
In nuclear spectroscopy, the net area under the measured photopeak in the 
spectrum is proportional to the concentration of the element of interest in the 
sample.  This linearity is maintained as long as there are no spectral distortions 
due to nonlinear effects during data acquisition.57  This is the case when spectra 
with low counting nets are collected.  The conventional approach to evaluating 
the net number of counts (N) in a photopeak that is not convoluted with additional 
peaks is the trapezoidal method (TM), which assumes a linear background under 
the photopeak.  For any given spectra, the trapezoidal method can be expressed as 
the total number of counts (T) in the selected region of the photopeak (referred to 
in the text as Total K Peak Counts), less the number of counts in the Compton 
continuum background (B) (referred to in the text as Compton Continuum 
Background K Peak Counts) that is determined by the area of the trapezoid below 
the photopeak (Figure 2.2.1-1). This is expressed as 
 
BTN −=      (2.2.1-1) 
 
and the variance associated with the net counts is, 
 
BTBTN +=+= 222 σσσ     (2.2.1-2) 
 
where σT  is the standard deviation in the total K peak counts and σB the standard 
deviation in the Compton continuum background K peak counts. 
For the specific case of this project, in order to determine the overall K 





measured and subtracted from a K spectra.  The presence of K in ambient room 
background, augments the statistical error propagation in the K signal in the case 
when the ambient room background K must be subtracted.  In this case, the 
overall net K peak counts and its variance is considered to be, 
 
BBOverall BTBTN −−−=     (2.2.1-3) 
 
NBBTNOverall
2222 σσσσ ++=     (2.2.1-4) 
 
where σ2NB is the variance in the net K peak counts of the K determination for the 
ambient room background.  For notation clarity, when the TM is applied to an 
ambient room background spectra, the net K peak counts for the ambient 
background is written as 
 
BBB BTN −=      (2.2.1-5) 
 
and the variance as 
 
BBTBNB




















Figure 2.2.1-1.  Trapezoidal method applied to a 10 gK water phantom 
spectrum for one hour taken with BNL Brain K single 3”x3” NaI(Tl) 
detection system.  (Net K peak counts (N) region is in yellow, Compton 
continuum background K peak counts (B) approximated by a 
trapezoidal shape in green, and total K peak counts as yellow 









Statistical Error Propagation Calculation For Brain K Measurement 
 
Brain K measurements consisted of two measures, 1) a background 
measurement for one hour, taken either prior to subject measurement or prior and 
after subject measurement, and 2) a subject measurement for one hour.  For the 
single background and single subject measurement case, uncertainty in Brain K is 
calculated using Eq. 2.2.1-4, and s 2NB was calculated using Eq. 2.2.1-6.  
However, for subject measurements where a background measurement was taken 
prior and after subject measure, the total K peak counts (TB) and the Compton 
continuum K peak counts (BB) for the background measurements are averaged, 















T were the total K peak counts for each background measure prior 

















B were the Compton continuum K peak counts for each 
background measure prior and after subject measure. 
















=2σ     (2.2.1-10) 
 
 
Thus, the total uncertainty in overall net K peak counts (N) for subjects with 




BT σσσ +++=    (2.2.1-11) 
 
where T and B are the total K peak counts and Compton continuum K peak 






2.2.2.  Stripping Method and Associated Statistical Error 
 
The stripping method uses the subtraction of entire or partial spectral 
regions of multiple spectra to generate a residual spectrum.  This method was 
applied to subtract a room background spectrum from a K spectrum.  This 
provided a K residual spectrum which was used to calculate the net K counts.  
Variance was calculated using Eq. 2.2.1-2, with T being redefined as the total 
number of counts in the K spectrum, and B as the total number of counts in the 
background spectrum. 
 
Statistical Error Propagation Calculation For Arm K Measurement 
 
To calculate the error resulting from counting statistics in the overall net 
result in grams K (net counts calculated by the stripping method), the statistical 
















    (2.2.2-1) 
 
 
Overall net counts (NS) was calculated by: 
 
BS TTN −=           (2.2.2-2) 
 
in the region of interest (K photopeak), where TS is the total number of counts in 
the K region of interest (ROI) from the K signal (from a subject or phantom), and 





photopeak region of interest is 18 channels wide and covers the entire photopeak 
spread.) 
Grams K was determined using the daily linear calibration equation on the 
day of subject measure: 
 
( ) ( ) ( ) ( )countsbgKxgKcountsacountsy ±⋅= /        (2.2.2-3) 
 
where a and b are the slope and intercept for a line, respectively.  For a subject 
measure, N was inserted into the y value of Eq. 2.2.2-3, and x calculated for each 
subject (S).  To calculate the SD of subject gK, Eq. 2.2.2-1 was applied to the 








































































where s 2a and s 2b are the variances for a and b, respectively.   
 
Statistical Variation in Repetitive Measurements For Arm K 
 
For a typical subject value, the SDS(gK) was calculated as 2.8%, when 
phantom calibration was taken on same patient day and the phantom background 
measure was taken before and after patient measure.  To take into account 
measurement variability, s 2a and s 2b were recalculated for a phantom calibration 
line from phantom measurements taken over a period of a month.  The variance 
increased by 6.7% for a and b.  Thus, using Eq. 2.2.2-4, the SD increased to a 





variation in arm PBK grams K values can be assumed to be less than 4%.  
However, for the arm PBK clinical analysis (Chapter 6), individual calculated SD 
for each patient measure from Eq. 2.2.2-4 were used. 
 
2.2.2.1.  Comparison of Two Samples 
 
To compare arm PBK values and TBK values with values from standard 
body composition indices, two statistical tests were applied, regression analysis 
and Student’s t-test for independent samples, in order to determine the degree of 
correlation between the two comparison indices and the probability (p-value) of 




Regression analysis is defined as a procedure to quantify the relationship 
between a measured variable and an independent process variable.  This analysis 
is used to define the relationship between the two variables that will be valid on 
average.  Regression analysis assumes that the variation in the dependent 
measured variable (y) will follow a normal distribution for each fixed value of the 
independent variable (x), for N number of measurements.  The correlation 








1 −=     (2.2.2.1-1) 
 
The standard deviation in x and y is calculated from the standard deviation in each 



















    (2.2.2.1-2) 
 
where yci is the value of the linear equation at data point (xi,yi).  The variance for 















         (2.2.2.1-3) 
 
The value, r, is considered the reliable relationship between y and x.  The value, 
r2, however, is indicative of the goodness of fit of the variance of y to the linear 




Two different Student’s t-tests can be applied to compare two samples.  
The t-test for two correlated samples assumes one variance for the population, 
which is defined as the two samples combined.59  The t-test for independent 
samples assumes that the two samples are independent and non-related.  For the 
specific cases of this project, the comparison between PBK with TBK, the t-test 
for two correlated samples could be used.  However, using the t-test for 
independent samples provides a more conservative estimate of the probability of 
correlation.  Thus, when using this t-test, for the linear regression analysis cases 
when high correlations occur, and a low p-value is calculated from the t-test, the 






t-Test For the Significance of the Means of Two Correlated Samples59 
 
To apply the t-test for two correlated samples, three assumptions are 
made: 
 
1) The measurement level is meaningful and contains equal- interval scale 
properties. 
2) The values of Di are randomly chosen from the source population. 
3) Each source (sample) population has a normal or near normal 
distribution.  
 
The two samples are considered arbitrarily statistically independent for one 
sample and statistically dependent for the second sample.  The two samples are 
considered “linked,” and a single mean and standard deviation for the differences 
between the two samples (eliminating what the two samples have in common) are 








=      (2.2.2.1-4) 
 














sµ is an estimate of the standard deviation ( Dµσ ) of the sampling 
distribution of  Dµ .  The difference (Di) is calculated by 
 




x is the measured value from the first sample xa for a subject i and 
ib
x is 
the measured value from the second sample xb for the same subject i.  When the 
variances of each sample are known, 
Dµσ is calculated by Eq. 2.2.2.1-7, and the 




















=              (2.2.2.1-8) 
 
However, when the variances for each sample are unknown, 
D





















µ     (2.2.2.1-9) 
 
where N is the number in the sample (same for both xa and xb, in this case).  This 
method assumes that the pre-existing individual differences with respect to the 
measured values  are extraneous and therefore does not overestimate the standard 





observed mean difference, as occurs when the t-test for independent samples is 
used for correlated cases.    
 
t-Test For the Significance of the Means of Two Independent Samples59 
 
An alternative method to calculate t, can be applied when the two samples 
are considered to be independent.  The same assumptions for the t-test for two 
correlated samples apply, except for the second assumption, which is re-defined 
as: 
 
2) The values from the two samples are independently and randomly 
chosen from the source population. 
 










=     (2.2.2.1-10) 
 
where axµ is the mean of the first sample (xa), bxµ the mean of the second sample 
(xb), and 
bxax
s µµ − is an estimate of the standard deviation of the distribution of the 
sample-mean differences (
bxax
µµσ − ).  Again, when the variances of each sample 
are known, 
bxax
µµσ − is calculated by Eq. 2.2.2.1-11, and the Student’s z-


































=     (2.2.2.1-12) 
 
Alternatively, when the variances for each sample are unknown, 
bxax
























µµ     (2.2.2.1-13) 
 
where ps 2 is the estimated standard deviation of the overall source population 
calculated by 
 
( ) ( )















    (2.2.2.1-14) 
 
For either t-test, the null hypothesis assumes that there is no difference 
between the means of the two samples.  The calculated value of the 
experimentally observed value of t (using either t-test), is compared with the t-
critical values for the various levels of significance (a) from the Student’s t-
distribution (one-tail or two-tailed).  Two-tailed t-distributions are assumed when 
the directional difference between the means of the two samples is unknown.  P-
values (i.e., a), the probability that the null hypothesis is true, is assumed to be 
significant for p < 0.05 (95% confidence level) or  p < 0.01 (99% confidence 
level).  Therefore, p-values less than 0.01 are considered to have a high 





In a statistical software package, such as Axum 7.0, the variance of the 
two separate samples can be identified as equal or non-equal variances.  
Calculating the t-test using non-equal variances reduces the probability of 
correlation for the cases where no correlation exists, and is assumed for a 
conservative estimate of probability of correlation. 
For the comparison of arm PBK and TBK to standard body composition 
indices, the t-test for two independent samples is applied, and the p-values used to 
determine the probability of correlation for high values of r2. 
 
One-Way ANOVA For Independent Samples 
 
 For the arm PBK and TBK values, the data was further sub-divided 
into three groups (cohorts) based on clinical criteria.  To compare these various 
clinical cohorts within a body composition measure (such as arm PBK and TBK), 
one-way analysis of variance (ANOVA) for independent samples was applied to 
generate the probability that the cohorts were statistically separate, independent 
samples. 
The assumptions for ANOVA analysis include the three assumptions 
mentioned for the t-test for two independent samples, with the second assumption 
redefined as: 
 
2) The values from the k number of samples are independent and randomly 
chosen from the source population; 
 
and one additional assumption included: 
 






In order to compare the means of the two samples, the Central Limit Theorem and 
its assumptions (not discussed here) is applied to the overall population (the 
samples combined).60  According to Stockburger, the Central Limit Theorem 
states: 
 
…the mean of the sampling distribution ( Xµ ) equals the mean of 
the population ( Xµ ), and that the standard error of the mean ( Xσ ) 
equals the standard deviation of the population ( Xσ ) divided by 
the square root of N.60  
 
In equation form, the Central Limit Theorem can be written as60 
 








σ =    (2.2.2.1-16) 
 
The standard deviation of the population can be estimated by two independent 
methods, the “within method” and the “between method.” 60  In the first method, 
Xσ is estimated by combining the variances for, or “within” each sample, also 


















where s is the estimated standard deviation for each sample.60  Using the second 
method, Xσ is estimated through the variance of the means (as estimated from the 
standard error of the mean squared) and the sample size N, referred to as the 




XB sNMS ⋅=            (2.2.2.1-18) 
 
To apply ANOVA, the f-distribution is used to compare the means of the samples.  
The observed f-ratio is calculated using the “Mean Squares Within” and the 






f =           (2.2.2.1-19) 
 
and is a measure of the difference of the sample means relative to the variance in 
each sample.60  Similarly, to the t-test, the observed f-ratio is then compared with 
the f-critical values for the various levels of significance (a) from the f-
distribution (a one-tail distribution).60  The larger the value of the experimentally 
observed f-ratio, the greater the likelihood that the difference between the means 
are not caused by random chance.60  For an ANOVA application, the f-ratio is 
used to test whether or not the null hypothesis (that there is no difference in the 
means) is true.  When fobs is larger than fcrit, the difference in the means is 
significant and not due to chance.60  Significance (or confidence) levels can be set 
to any arbitrary value, however, the larger the p-value (i.e., a), the smaller the 
confidence level.60  Confidence levels of p < 0.05 (95% confidence level) or  p < 
0.01 (99% confidence level) are considered to have a high probability that the 





2.2.3.  Library Least-Squares Method57,61,62,63,64 
 
The Library Least-Squares (LLS) method relies on the fundamental 
assumption that an unknown measured spectrum, bi, is a linear superposition of 
the contributions from all the elements present in a sample.  Analytically, the 
sample’s elements are expressed as reference standards, or library standards, aij, 
which contribute a fraction xj to the measured spectrum.  Therefore, the LLS 





ji Eaxb ±⋅= ∑
=1
,   i = 1, 2, ..., n   (2.2.3-1) 
 
where i is the channel number from 1 to n, m is the number of elements present in 
the sample, and Ei is the random statistical error between the model and the 
measured spectrum in channel i.  The objective of Eq. 2.2.3-1 is to find a set of xj 
values tha t minimizes the statistical error term E.  One method is to sum the 
squares of the statistical error terms to avoid positive and negative values, and 
equating the first derivatives of the statistical error term with regard to the xj's to 
zero.  Usually in this method, the statistical error term is replaced with a Chi-
square term and minimizing the χ2 from which the xj values are derived 














χ     (2.2.3-2) 
 
where s i is the standard deviation of Ei and the set of equations to be solved for 













  ,  j = 1 to m   (2.2.3-3) 
 
Statistical error propagation in the calculated xj values is minimized by acquiring 
the library standards aij with very high statistics.  This allows the statistical error 
contributions due to aij to be discarded in the statistical error matrix and not 
contribute to overall statistical error propagation.   
To solve Eq. 2.2.3-3, Eq. 2.2.3-1 is rewritten in matrix form,  
 
































    (2.2.3-6) 
 
{ }jxX =~      (2.2.3-7) 
 
and Eq. 2.2.3-4 is solved by  
 
BAX ~~~ 1 •= −     (2.2.3-8) 
 
Using weighted library least squares, the weighing factor s i2 in Eq. 2.2.3-2, which 












jii axb σσσ ∑
=
+=    (2.2.3-9) 
 
where s 2(bi) and s 2(aij) are the variances of bi and aij.  If assume Poisson counting 
statistics, Eq. 2.2.3-9 reduces to 
 
iji ab +=
2σ     (2.2.3-10) 
 
Furthermore, when the library spectra are accurately known, and the statistical 
fluctuations in the count rate are the primary source of statistical uncertainty, Eq. 
2.2.3-10 further reduces to 
 
ib=
2σ     (2.2.3-11) 
 


































































































































































which is solved by Eq. 2.2.3-8.  The matrix equations and solution for a given set 
of libraries and unknown spectra are calculated using the FORTRAN program in 





2.2.3.1. Statistical Error Estimation For Library Least Squares 
Method57,61,62,63,64 
 
Standard Deviation of xj 
 
The variance of the xj factor for each library Aij, is estimated us ing a 

















































2 )()()( σσσ ,  j = 1, 2, …, m   (2.2.3.1-1) 
 
Again, when the standard libraries are accurately known and are taken for 
sufficient count times to generate good counting statistics, the second term is 





































•−= −σ ,  j = 1, 2, …, m (2.2.3.1-2) 
 


















   (2.2.3.1-3) 
 
where RR are the relative residuals (discussed in next section), 1
~ −
jjA  the value in 





subroutine AINV in Appendix A.1), and (n-m) the degrees of freedom, where n is 




The relative residuals are a useful feature of the LLS method which allows 
the deviation of the standard libraries to the unknown spectra for a given channel i 
to be plotted and observed.  Deviations larger than 3 to 5 s indicate the poorness 
of fit of the libraries to the unknown spectra in the specified channel, and may 
also indicate the need for additional libraries, or possibly instrumentation error in 
the data (For further detail, see Chapter 5.3.3).  For the LLS method, relative 









=    (2.2.3.1-4) 
 
where the relative residuals (RR) are defined as the difference, in a given channel 
i, between the unknown spectrum Bi to a library aij multiplied by the fraction xj, 
(where xj produced the minimized sum of the squares of all statistical errors), 




The chi-squared test, for the LLS method, is used as an indicator of the 
goodness of fit of the unknown spectra to the standard libraries.  A chi-squared 
value approximately equal to unity is indicative of a good fit.  Small or negative 
values of chi-squared indicate that the assumed distribution of the library spectra 





sample data are not a good representation.  Large values of chi-squared are 
indicative of larger deviations than expected from the fit of the assumed library 
spectra to the unknown spectra.   
Chi-squared is a statistic that characterizes the dispersion of the observed 
values from the expected values (or frequencies) of a measure or function.  The 














χ     (2.2.3.1-5) 
 
where the overall equation is a measure of the observation spread, and the 







2 =ducedRe            (2.2.3.1-6) 
 









2χ           (2.2.3.1-7) 
 
where R are simply the non-relative residuals (Eq. 2.2.3.1-8). 
 










There are several possible sources of systematic error or uncertainty due to 
phantom composition.  Some of the possible sources of systematic error are listed 
in Table 2.3-1. 
 
Table 2.3-1.  Some sources of systematic error in phantom composition. 
(Modified from Bewley D.K., 1998.65) 
 
1) Systematic Error in mass measurement of phantom 
2) Uncertainties in manufacturer’s chemical assay 
3) Water saturation of chemicals in storage 
4) Water vapor loss of phantom 
5) Impurities in phantom plastics or chemicals 
 
Investigations into the systematic error contributions of whole body phantoms for 
a variety of phantom materials and elements were reported by Bewley, and the 
maximum uncertainty in a phantom containing K was considered to be 2-5%.  
This was determined by calculating the systematic error separately for each of the 
five sources of uncertainty listed in Table 2.3-1 and combining into a total 
uncertainty.  As reported by Bewley, for the separate sources of systematic error 
listed in Table 2.3-1, first, the systematic error in the mass measurement was 
considered negligible.  Second, the uncertainty associated with the chemicals was 
determined to be 0.1-1%.  For the water saturation of chemicals in storage, the 
error contribution was up to 1% for NaCl and from the similarity in molecular 
weight to KCl could be extrapolated to approximately the same for KCl.  From 





well within the uncertainties previously calculated for previous three sources of 
error.  Finally, impurities in the plastics were estimated to add about 1%.  
Combining these errors, Bewley reported an overall systematic error from 
composition of 1% for K. 
For the phantoms used to calibrate the systems assessed in this work 
(described in Chapter 3.2) , the systematic error in the phantoms for the first three 
sources of error listed in Table 2.3-1 was determined as follows: 1) the error in the 
mass measurement was considered to be 0.001% due to the high precision of the 
balance, 2) the uncertainty in the chemicals was listed as 0.1%, and 3) the error 
contribution from the water saturation of the chemicals was assumed to be 
approximately 1%, as determined by Bewley.  For the fourth source of error, this 
was calculated by the difference in total K peak counts for a given phantom over 
time.  For the brain K phantoms, the error associated with loss of water vapor 
over time was considered to be within 1σ (standard deviation), or 7%, of the 
statistical error associated with repetitive measurements, calculated by the TM 
method (This is discussed further in Chapter 3.2.)  However, using the LLS 
method of analysis to measure phantom background minimizes this contribution 
to within the 1% error associated with statistical fluctuations in the background.  
For the arm K phantoms, error associated with water vapor loss, was estimated to 
be within the standard error of the mean (0.1-0.4%) of repetitive measurements of 
phantoms over time using the TM method.  Finally, the impurities in the rubber 
(brain K phantoms) or plastic (arm K phantoms) containers were considered 
negligible and within statistical fluctuations.   Thus, combining all errors, the total 







Size and Location 
 
According to Shukla, K.K., et al.,14 40K measurement by TBK using a 54 
detector system, has been shown to be independent of size and habitus (body 
build) of the subject.  The contribution to uncertainty from location of the subject 
can be determined by repetitive measurement of a subject or phantom, to 
determine the precision of the measure.  For TBK, the precision has been 
determined to be 1.0-5.0%.  Most often, the precision is quoted in the literature as 
1.5%.  (The precision of the arm PBK measure has been determined to be 0.2% in 
net K counts using the stripping method for repetitive measurements of phantoms, 
and the statistical error, on average, 5.5% for subject measure.) 
 
Other Sources of Systematic Error 
 
One possible source of systematic error is the difference in size from the 
phantom to the organ of measurement.  For this project, this is assumed 
negligible, however, a more rigorous extrapolation using MCNP would be needed 
to more accurately assess this error contribution.  A further source of error could 
be the differences in internal material composition of the phantom (water and 
KCl) to the internal material (tissue) of the organ measured.  The mass attenuation 
coefficient for a 1.5 MeV gamma ray, is slightly different for tissue than for 
water, although water or agar has been used as an acceptable substitute in the 
literature, and may cause variations up to 3%.  However, for this project, 
uncertainties from material variations are considered within the statistical 
uncertainties of the numerical analysis calibrations of the phantoms.  Therefore, 
for the remainder of the chapters, statistical uncertainty will be the reported value 





2.4.  Detector Assessment: Sensitivity and Minimum Detection Limit (MDL) 
Calculations  
 
The various performance parameters of a system can be derived from two 
minimal quantities.  One, the sensitivity (Y), or yield, given in counts per gram 
per unit time (c/g/h), and two, the background (B) given in counts per unit time.  
From these values, other parameters such as signal-to-noise ratio (S/N) and the 








=      (2.4-1) 
 
where S is the K signal, and noise, N, is approximated by the square root of the  
Compton Continuum background (B) for the K region of interest (ROI).  From the 
determination of B, MDL is defined as 
 
 BackgroundSDMDL ⋅= 3     (2.4-2) 
 
where SDBackground is the standard deviation of the Compton Continuum 
background counts ( )B  in the K ROI.66   
For the trapezoidal method, the K signal from a measured spectrum is 
obtained by calculating the net counts using Eq. 2.2.1-1.  The standard deviation 
of the K signal is calculated using Eq. 2.2.1-2, assuming Poisson statistics.  
Furthermore, in the case, when an ambient background spectrum is subtracted 
from the measured spectrum, the K signal is obtained from the overall net counts 
(Eq. 2.2.1-3), and the standard deviation of the K signal given by Eq. 2.2.1-4.  





with T and B redefined as given in Chapter 2.2.2, and the standard deviation 







3. Initial Calibration of Experimental Setup and Associated Phantoms and 
Ambient Room Background Assessment 
 
Experiments were conducted at three different sites with three different 
systems that were partially optimized for measurements of K in different parts of 
the human body.  Although all three systems used NaI(Tl) detectors, they vastly 
differed in their general configurations.  The BNL system was constructed to 
measure K in the brain, the SLR system was constructed to measure K in the arm, 
and the BVA system was build to facilitate K measurement in the limbs of 
paralyzed subjects.  In either case, the systems were initially calibrated and 
characterized using phantoms and a K point source followed by clinical 
measurements on real subjects.  The systems, their calibrations and the results are 
presented below.  
 
3.1. Experimental Set-ups  
 
Brain K Measuring System 
 
Basic set-up to measure K in the brain constructed at BNL consisted of a 
single 7.6 cm high by 7.6 cm in diameter (3”x3”) NaI(Tl) scintillation detector 
surrounded by lead shielding.  The detection system was placed on an adjustable 
table positioned at the head of a bed; the physical set-up is shown in Fig. 3.1-1 
and a schematic of the internal configuration shown in Fig. 3.1-2.  Although not 
crucial to this experiment, the detection system was housed in a low background 
shielded room, fabricated with pre-World War II submarine steel (Fig. 2.1-1).  
The steel of this facility has less 137Cs contaminates than materials fabricated 
during and after the atmospheric weapons testing of the 1960’s and 1970’s.44  The 





comfort.  Both materials were tested and found to have low potassium contents.  
The detector was surround by 5 cm lead shielding, with a 14 cm thick lead base, 
to shield from the high concentration of K in the paint of the support table.  The 
support table consisted of a hydraulic bench, with a lead wedge to support the 
weight at the desired height, for safe ty.  
The detector was connected to standard nuclear spectroscopy electronics 
that included a power supply (EG&G ORTEC-556), preamplifier (EG&G 
ORTEC-113), spectroscopy amplifier (EG&G ORTEC-673), and a multi-channel 
analyzer (MCA, Oxford-Win Version 3.80, PCA-3).  The electronics block 
diagram is schematically depicted in Fig. 3.1-3.  The purpose of the BNL set-up 
was to determine the detectability of the K signal in the brain.  The final system 
for clinical detection of K in brain envisions multiple, four or five, detectors 
surrounding the head and coupled through a sum amplifier to a single MCA.  A 
preliminary configuration of four 5”x3” NaI(Tl) detectors without lead shielding 
to measure brain K (Fig. 3.1-4) was used to determine improvements in the 








































Figure 3.1-1.  BNL set-up showing the detection system surrounded 

























Figure 3.1-2.  Internal configuration of the BNL 
































































Figure 3.1-3.  Block diagram of the electronics used with a single 




















Figure 3.1-4.  Schematic of the BNL four detector  










Arm K Measuring System 
 
The Arm K Measuring System constructed at SLR (referred to as the SLR 
system) consists of four square NaI(Tl) detectors 10 cm by 10 cm and 40 cm long 
arranged in a cross configuration creating a 10 cm by 10 cm cavity.  The detectors 
were surrounded by approximately 20 cm of lead shielding on the side and 10 cm 
at front and back of the detectors.  The detector arrangement is schematically 
shown in Fig. 3.1-5 and the subject positioning for arm measuring is shown in 
Fig. 3.1-6.  The system was located underground in a hospital basement room, 
constructed with 15 cm thick concrete walls.  
The electronics configuration was similar to that at BNL with the 
exception of the amplifier (EG&G ORTEC-575), that was used instead of model 
673.  In addition, the amplifier outputs were fed into a sum amplifier (ORTEC 



































































Figure 3.1-6.  Artistic view of the SLR system with a subject 
posed for arm K measurement. 





Extremities K Measuring System 
 
In contrast to the two previous systems, the system to measure K in  
paralyzed subjects, constructed at BVA, is of an open type geometry instead of 
closed type in order to accommodate subject positioning.  It employs two large, 
10 cm by 10 cm by 45 cm, NaI detectors and standard nuclear electronics similar 
































Figure 3.1-7.  Schematics of the BVA open system using two 
detectors for paralyzed subjects. 
Foam Detectors  






3.2.  Phantoms 
 
The K measurement systems were evaluated and calibrated using 
phantoms that simulated the pertinent parts of the human body of interest.  
Phantoms are typically filled with water or tissue equivalent liquids depending on 
the purpose of use and radiation type, x-rays, gamma rays or neutrons.  A 
discussion of phantoms used for the whole human body can be found in Bewley 
1988 and specifically for whole body K measurements in Ellis et al., 1991.65,67  
These phantoms constructed for use with the Brain K Measuring System and the 
Arm K Measuring System, were first approximations of the general geometry of 
the partial body regions of interest for this project.  A sphere was used to 
approximate the same volume and K concentration as the human male brain, as 
defined for Reference Man.17  A larger sphere was used to approximate the 
volume of the entire head.17  Similarly, a rough cylindrical shape was used to 
approximate the width, length, volume, and K concentration of the human male 
arm.17  The range of K concentrations chosen for the calibration phantoms in 
either case (Brain or Arm) were designed to have the reference value central in 
the calibration line.  (Calibrations are discussed further in Chapter 3.3.)  Phantoms 
were used for both calibrations and characterizations of the systems. 
 
Brain K Measuring System 
 
The phantoms used for partial body K measurements in brain at BNL 
consisted of four identical rubber spheres of 1.43 liters (L), filled up with distilled 
water containing 0, 3.8, 7.6, and 19.1 grams of KCl, molecular weight (74.548 
cm3/g), corresponding to 0, 2, 4, and 10 g of K, respectively.  An example of this 
sphere, referred to in the later text as ‘small water phantom,’ is shown in Fig. 3.2-





only and used for system characterizations.  This phantom is referred to as the 
‘large water phantom,’ in the text (Fig. 3.2-1).  A point source consisting of 9.1 g 
K enriched with 5.2% 40K encapsulated in a 4 cc molybdenum glass vial was 
used to assess additional system characteristics in conjunction with the water 
phantoms.  Experiments with the point source were conducted in air, with the 
water phantoms, and in a water bath constructed of Lucite® with dimensions of 48 
cm wide by 48 cm long by 41 cm high and 0.64 cm thick.  Furthermore, 
experiments were also conducted with the water phantoms in a KCl bath 
containing 1.75 gK/1600 ml concentration. 
 
Arm K Measuring System 
 
Phantoms used for calibration and system characterization of the partial 
body K measurements in the arm at SLR consisted of commercially found plastic 
water bottles, as a first approximation for calibration (Fig. 3.2-2). SLR phantoms 
consisted of three sets, 1.5 L, 0.5 L, and 0.25 L (referred to later in the text as 
‘large,’ ‘medium,’ and ‘small,’ respective ly), with five bottles in each set.  
Dimensions of each phantom size were 30 cm high by 8 cm in diameter (large), 
20 cm high by 6 cm in diameter (medium), and 11 cm high by 6 cm in diameter 
(small), respectively.  Each set contained KCl in the amounts of 0, 9.5, 19.1, 28.6, 
and 38.0 grams corresponding to 0, 5, 10, 15, and 20 grams of K, respectively.  
The large 1.5 L set was used for calibration purposes.  The other two sets were 
used for system characterization.  The point source (previously described in the 
Brain K Measuring System phantom section) was also used with the Arm K 

















Figure 3.2-1.  Small and large water phantoms used for calibration and 










































1.43 L 0.5 L 
0.25 L 
1.5 L 30 cm 
20 cm 
11 cm 14 cm 
Figure 3.2-2.  Large, medium, and small water phantoms for the SLR 
Arm K Measuring System for calibration and system characterizations.  






3.3. Calibrations  
 
3.3.1. Energy Calibration 
 
Prior to system phantom calibration, both the BNL Brain K Measuring 
System and the Arm K Measuring System were energy calibrated.  Standardized 
calibration sources of 137Cs and 60Co were used to establish the relationship 
between photopeak energy and channel number displayed on the multi-channel 
analyzer, and a linear regression line was generated through the data points.  The 
equation was input into the MCA, to display the spectra in counts versus energy 
(in keV), rather than channel number.  137Cs was also used to inspect the output of 
the various electronic modules.  To address gain shifts of the system from NaI(Tl) 
due to crystal expansions or contractions from room temperature changes or due 
to other conditions, the 137Cs and 60Co sources were used to adjust the fine gain of 
the amplifier to move a centroid of a photopeak for each source (662 keV for 
137Cs and 1332 keV for 60Co, respectively) to the correct energy reading on the 
MCA, thereby maintaining energy calibration. 
 
3.3.2. Phantom Calibration 
 
Brain K Measuring System 
 
System response was calibrated for various K concentrations.  Levels of K 
in the brain were simulated with the four small water phantoms containing 0, 2, 4, 
or 10 grams of K as dissolved KCl (described in Chapter 3.2).  The phantoms 
were placed in contact with the unshielded front face of an otherwise shielded 
detector with two inches of lead.  The spectra from the various KCl filled 





the trapezoidal method (described in Chapter 2.2.1).57  The calibrations were 
repeated both subsequently per day and over time (a period of two years)  The one 
hour interval was chosen as suitable for clinical measurements (and clinical data 
were measured using the same time interval), and the 18 hour interval calibration 
measurements were performed to improve the counting statistics. 
The calibration data with the generated linear calibration lines are listed in 
Table 3.3.2-1, with the standard deviation of the individual measurements and the 
standard error for the coefficients of the linear regression calculated.46  The data 
points with the linear calibration line used for subject measurements (discussed in 
Chapter 6) is shown in Fig. 3.3.2-1 (r2 = 1.0), with error bars representing the 
standard deviation of the individual data measurements.  The numerical data 
values for Fig. 3.3.2-1 are listed in Case 3 of Table 3.3.2-1.  For Fig. 3.3.2-1, three 
phantoms were used instead of four, since one phantom lost coherence.  The room 
background net K peak counts for Case 3 (the calibration line shown in Fig. 3.3.2-
1), are slightly higher than Case 1 or 2 listed in Table 3.3.2-1, since this series was 
taken with room door open (versus closed, as presented in Case 1 and 2), as were 
the subject measurements (in accordance with IRB protocol).  The calibration in 
Fig. 3.3.2-1 was used to minimize introducing further error from different 
background conditions (open versus closed room) in the subject measure 
calculations.  Furthermore, the phantom calibration shown in Fig. 3.3.2-1 was 
measured concurrently with the subject measurements to minimize error being 
introduced by room background fluctuations over time.  (Fluctuations in the 
ambient room background is discussed further in Chapter 2.1.4 and experimental 
assessment of ambient room background is discussed in Chapter 3.4.)  However, 
the uncertainty introduced by the background conditions is well within the 








Figure 3.3.2-1.  Calibration line for Brain K Measuring System 
(using single 3”x3” NaI(Tl) detector). 
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Table 3.3.2-1.  Overall net K peak counts versus grams K content in small water phantoms with calibration 
lines, y = ax + b, fitted to data points derived from water phantom measurements for 1 hr.46 
 
Overall Net K Peak Counts ± SD (counts) Case 
0 gK a 2 gK b 4 gK b 10 gK b 
Slope 
a ± SE c 
Intercept 
b ± SE c 
1 0 ± 22 e 86 ± 35 222 ± 37 654 ± 45 67.0 ± 3.8 -27.5 ± 21.0 
2d 0 ± 6 f 124 ± 8 247 ± 9 579 ± 10 57.6 ± 1.2 7.1 ± 6.6 
3d 0 ± 10 g N/A 241 ± 10 596 ± 11  59.5 ± 0.2 0.79 ± 1.4 





2 sss += . 







2 ssss ++=Overall . 
c Standard error in the coefficients of the linear regression. 
d Converted from 18 hr measurement. 
 e NBackground = 115 ± 22. 
 e NBackground = 114 ± 6. 







Arm K Measuring System 
 
To calibrate the Arm K Measuring system, arm potassium levels were 
simulated using 1.5 L water phantoms with dissolved KCl in the amounts of 0, 5, 
10, 15, and 20 grams of K.  The phantoms were placed inside the cavity with the 
top of the bottles at the front edge of the detector, 10 cm within the shielding.  
The spectra from the phantoms was acquired for 15 minutes (the same interval as 
the clinical measurements), and analyzed using net counts in the photopeak after 
background subtraction.  Multiple calibration lines were analyzed and all 
calibration lines were strongly linear (R2 = 0.98 or higher).  An example of a SLR 
calibration line is shown in Fig. 3.3.2-2.  Examples of 12 repetitive calibrations 
are listed in Tables 3.3.2-2 and 3.3.2-3, with the data points, calcula ted standard 
deviations (Table 3.3.2-2), and the respective calibration line equations shown 
(Table 3.3.2-3).  Reproducibility in the calibration data was high, with total K 
peak counts and net K peak counts for all data points within 1% standard 
deviation for individual measurements and within 0.2% standard error in the mean 
for the population shown in Table 3.3.2-2.  The 0.2% standard error in the 
population (for total K peak counts) was consistent for calibration data observed 








Figure 3.3.2-2. An example of a typical calibration line for the  
SLR Arm K Measuring System. 
(Data for Fig. 3.3.2-2 is listed in Table 3.3.2-2.) 
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Table. 3.3.2-2.  Total K peak counts and net K peak counts for repetitive measurements 
of various K concentration water phantoms. 
 
a Shown in Figure 3.3.2-2. 
 
 




















































1 5348±73 0±73 8795±94 3447±119 12131±110 6783±132 15763±126 10415±145 19364±139 14016±157 
2 5389±73 0±73 8846±94 3457±119 12213±111 6824±133 15484±124 10095±144 18935±138 13546±156 
3 5327±73 0±73 8636±93 3309±118 12188±110 6861±132 15833±126 10506±145 19232±139 13905±157 
4 5276±73 0±73 8776±94 3500±119 12234±111 6958±132 15457±124 10181±144 18798±137 13522±155 
5 5399±73 0±73 8599±93 3200±118 12306±111 6907±133 15673±125 10274±145 19305±139 13906±157 
6 5298±73 0±73 8760±94 3462±119 12137±110 6839±132 15827±126 10529±145 19240±139 13942±157 
7 5538±74 0±73 8937±95 3399±120 12189±110 6651±133 15816±126 10278±146 19019±138 13481±157 
8a 5370±73 0±73 8937±95 3567±120 12089±110 6719±132 15498±124 10128±144 19284±139 13914±157 
9 5381±73 0±73 8259±91 2878±117 12019±110 6638±132 15575±125 10194±145 19275±139 13894±157 
10 5295±73 0±73 8865±94 3570±119 12150±110 6855±132 15725±125 10430±145 19100±138 13805±156 
11 5345±73 0±73 8751±94 3406±119 12051±110 6706±132 15926±126 10581±146 19144±138 13799±156 
12 5543±74 0±74 8799±94 3256±120 12248±111 6705±133 15517±125 9974±145 19108±138 13565±157 
Mean 5375 -- 8747 3371 12163 6787 15675 10299 19150 13775 
SDPopulation 86.1 -- 184.5 16.0 83.7 8.6 162.8 192.7 167.8 191.2 






Table. 3.3.2-3.  Associated calibration line equations for repetitive 

















Case Slope ± SE  
Intercept 
± SE 
1 700.0±6.8 -67.8±82.9 
2 674.6±3.5 38.4±43.0 
3 700.1±6.3 -85.2±77.1 
4 674.5±6.2 87.2±75.7 
5 697.7±8.6 -119.8±105.4 
6 699.0±5.3 -35.8±64.7 
7 676.8±6.6 -6.4±80.8 
8a 687.8±11.6 -12.2±142.5 
9 702.1±17.6 -300.0±215.4 
10 689.4±4.8 38.0±59.4 
11 695.5±10.7 -56.2±130.7 
12 677.0±6.3 -69.6±77.1 
Mean 689.5 -49.1 
SDPopulation 11.4 98.7 





3.4.  Experimental Assessment of Ambient Room Background 
 
A confounding aspect of the ambient room background is its variability 
with time, consequently it is important to assess the degree of the fluctuations in 
the intensity of the ambient background.  This assessment would dictate whether a 
constant ambient background can be considered for the PBK analysis or whether 
the ambient background is required to be measured each time prior to the subject 
analysis.  In addition, characterization of the degree of changes in the spectral 
shape of the background is particularly important when using the LLS method for 
spectra analysis in which the ambient background spectrum is used as one of the 
libraries.  (The LLS method is discussed further in Chapter 5.) 
 
Mean Ambient Room Background at BNL and SLR  
 
The background was assessed, at BNL and SLR, over extended periods of 
time (using the TM for spectral analysis).  At the BNL site, the measurements 
were carried out in: 1) a low background shielded room that was used for whole 
body counting and 2) in a regular laboratory with normal ambient background.  In 
the BNL shielded room, the fluctuations in the total counts in the K photopeak 
ROI were found to be about ± 5%.  However, in the BNL laboratory, the total 
number of counts in the K photopeak ROI was about a factor of five higher than 
that found in the shielded room with similar variations.  The mean counts in the 
net K from the BNL shielded room and the BNL laboratory also differed by the 
same factor of five, however, with a larger dispersion (SD) in the net K counts of 
7% and 21%, respectively.  The second site was located in the basement of the 
SLR hospital where a PBK unit for arm measurements is located.  This heavily 
shielded system, consisting of four large volume detectors, had a 50-fold increase 





the shielded room at BNL, however, with half the fluctuations.  The actual mean 
background values for these two sites and the fluctuations in the background (as 





Table 3.4-1. Mean values and standard deviations (SD) of one -hour 
backgrounds collected at BNL shielded room (BNL-SR), a laboratory 




Total K Peak 
Counts 





± SD (%)a 
Net K Peak 
Counts 
± SD (%) 
BNL-SR 432 ± 5 282 ± 7 151 ± 7 
BNL-Lab 2131 ± 5 1330 ± 5 801 ±21 
SLR 21492 ± 2 15156 ± 3 6336 ± 5 
 





Effect of Detector Size on Ambient Background Assessment 
 
The fluctuations observed in the ambient background at the two sites were 
primarily in the amplitude of the spectrum, while the spectral shape remained the 
same.  Changing the detector size did not affect the shape in any discernable way.  
Ratios of the spectral areas for these detectors and their volumes are presented in 
Table 3.4-2, with the spectral shapes shown in Fig. 3.4-2.  It appears that in this 
case, the increase in the background is proportional to the detector's volume and 







Table 3.4-2. Comparison of the detection volume ratios with those obtained 
from the measured spectral areas at BNL. 
 
 
Detector Size (V inch3) Volume Ratio Spectral Area 
Ratio 
3”x3”  (21) 1 1 
5”x3”  (59) 2.8 3.3 








Figure 3.4-2.  One hour ambient background spectra acquired 
with three different detectors.   






Effect of Ambient Background Location on Spectral Shape  
 
From the small to large (5-21%) fluctuations in the net K counts of the 
ambient background for the two investigated sites, it can be concluded that when 
using the TM for spectral analysis, caution must be exercised to determine 
whether a constant ambient background assessment can be assumed or if an 
ambient background assessment measured prior to the human subject needs to be 
used for the analysis.  However, when using the LLS method for spectral analysis, 
this problem does not exist since the fit of the background library automatically 
accounts for these variations.  (This aspect of LLS is discussed further in Chapter 
5.)  Fluctuations in the ambient background were determined to be 1% or less, 
when analyzed with the LLS, for the same spectra from the BNL shielded room. 
Nevertheless, spectral variations in the ambient background were observed 
when the BNL ambient background spectrum was compared to an ambient 
background spectrum measured at SLR.  To assess the amplitude changes 
between the spectra, the count values in the tail region of the 210Bi peak were 
normalized.  The observable changes are shown in Fig. 3.4-3. 
The 210Bi photopeak from the Th decay series in the SLR spectrum is 
higher by a factor of two than that at BNL, thus increasing the total counts in the 
K photopeak ROI, when using the TM for spectral analysis.  The higher Th 
ambient background in the SLR spectrum is possibly emanating from the bedrock 
foundation surrounding the underground SLR facility.  On the other hand, the 
reduced low energy region of the spectrum is attributed to the heavy shielding 
surrounding the SLR detectors.  Therefore, when using the LLS, the  background 
library standard for the two sites cannot be interchanged since the spectral shape 
change is considerable.  As discussed further in Chapter 5, whereas the LLS can 





propagation (SD of 5s or greater), supports the use of an ambient background 

















Figure 3.4-3.  BNL and SLR 15 minute background spectra normalized at 



















Effect of Lead Shielding on Ambient Background Detection 
 
For constructing an open (i.e., partially collimated), mobile PBK detection 
system, as envisioned for the leg PBK detection system (see Fig. 3.1-7), tightly 
packed lead (Pb) shielding around the detectors will be required to reduce the 
ambient background sufficiently to observe the PBK signal from the extremity.  
The reduction in ambient background as a function of Pb shielding thickness was 
partially assessed by surrounding a single 3”x3” NaI(Tl) detector with various 
thicknesses of lead shielding in the BNL laboratory room.  The results for 0, 5, 
and 10 cm of Pb shielding using TM analysis are listed in Table 3.4-3.   
The results suggest that the net K counts in the K photopeak ROI are 
attenuated by the 10 cm of lead by a factor of 30, about 3% transmission, whereas 
the general background, as represented by the Compton continuum background 
ROI counts in the K photopeak, is reduced only by 11%.  Considering that the Pb 
mass attenuation coefficient is 0.0517 cm2/g (at 1.5 MeV) and Pb density is 11.9 
g/cm3, the Pb linear attenuation coefficient at 1.5 MeV is 0.61 cm-1, resulting in 
one mean free path of 1.62 cm.  Thus, three mean free paths, 4.87 cm, is about 5 






Table 3.4-3. Ambient room background reduction using lead shielding at BNL-Lab. 
 
Total K Peak Counts 
± SD (counts) 
Compton Continuum 
Background K Peak 
Counts ± SD (counts) 
Net K Peak Counts 




Counts Reduction Counts Reduction Counts Reduction 
None 8060 ± 90 1.0 4464 ± 67 1.0 3596 ± 112 1.0 
5 (2”) 996 ± 32 8.1 708 ± 27 6.3 289 ± 41 12.4 







4. Region-Specific Calibration of Experimental Set-Up With Associated 
Phantoms 
 
4.1. Phantom Calibration 
 
Brain K Measuring System 
 
During brain K measurement, one of the concerns is the potential 
contribution to the K photopeak from K located in the other regions of the head.  
The head is a concern since it is the closest external source of K, outside of the 
brain K, to the detection system.  Based on the resultant contribution from the 
head, the contribution from the rest of the human body, will be of lesser 
contribution than the head due to the greater distance from the detection system, 
and therefore the greater attenuation of the K signal from the body. 
To estimate the K signal contribution from the head, an experiment 
comparing a 10 gK small water phantom to a 0 gK small water phantom with an 
approximately 10 gK point source placed directly behind the 0.0 gK phantom 
opposite to the detector (point A, in Figure 4.1-1) was conducted.  The overall 
external head K contribution, from the skin outside the head, the cranial muscles, 
and the bone of the skull were estimated to be 1.9 gK, as postulated from 
Reference Man.17   The ratio of the net K peak counts from the 0 gK water 
phantom and 10 gK point source combined versus the 10 gK water phantom was 
0.23.  The attenuation of the K signal from distribution in a water phantom as 
compared to a point source distribution was assumed to be the difference in the K 
signal contribution from the brain as compared to a point on the surface of the 
head at point A.   Extrapolating from the 10 gK point source to the estimated 1.1 
gK present in skin, muscles, and bone above the quadratus labii muscle region 





skull was estimated to be 2-3% of the net K photopeak value from a small 10gK 
water phantom.46,68  Alternatively, estimating from the ratio of the maximum 
postulated external K contribution of 1.9 gK to the 4.2 gK present in the brain, 
dividing by a factor of 100 (dilution of 1.9gK to total brain mass of 1420 g), and 
multiplying by 0.23, yields the overall external K determination to be 0.01%, or 
1% extrapolated for a four detector brain system with a factor of 10 signal 
improvement (1.9/4.2/100x0.23x10).  These low values are attributed to the 
location of the external K, i.e. its distance and solid angle from the detector, and 
the self-attenuation by the brain region.   
The small and large water phantoms, and a point source placed at the 
points A, B, C, and D, shown in Fig. 4.1-1, provide a mapping of the K 
contributions of a 9.1 gK point source at the various points for distances 
surrounding the brain and the head, respectively.  The various ratios of net counts 
from the water phantom versus air measurements at each point, summarized in 
Table 4.1-1, agree with water linear attenuation values calculated for 1.5 MeV at 
point A, and are representative at the other point values.  Extrapolating for 1gK at 
the various points, gives contributions of 1.3 to 9.6% depending on location, or 
0.1% for 0.01gK at any location on the spherical cranial surface area. 
From experiments conducted with a point source in air and in a water bath, 
with the same configuration as Fig. 4.1-1, the volume of the brain was found to 
act primarily as an absorber, as concluded from the reduction of net K peak 
counts when water bath to air point source measurements for the same locations 
were compared.  In addition, the volume of the brain was found to act to a lesser 
extent as a scattering medium, as concluded from the slight increase in total K 
Compton counts for the water bath measurements as compared to the air 
measurements.  However, the low counting statistics for these experiments, 





counting times, these effects may be within the statistical error and not 
discernable.   
Further preliminary experiments conducted with a Lucite® shield as an 
initial cranium phantom, placed between the detector and a small water phantom 
with a point source at point A (Fig. 4.1-1), suggested the cranium would act as a 
scattering medium.  Approximately a reduction to half of the net K counts was 
measured using a 2.54 cm Lucite® shield (equivalent to an optical thickness of 1.7 






















Figure 4.1-1. Experimental setup to assess the K contribution from 






































Table 4.1-1.  Overall net K peak counts (± SD in counts) for 9.1 gK 
point source at coordinates A-H (Figure 2.4-1) in air and 











A 534 ± 23 262 ± 16 0.49 
B 462 ± 21 338 ± 18 0.73 
C 656 ± 26 632 ± 25 0.96 
Small  
D 1159 ± 34 1081 ± 33 0.93 
A 130 ± 11 0b 0 
B 99 ± 10 0b 0 
C 219 ± 15 28 ± 5 0.13 
Large  
D 561 ± 24 210 ± 15 0.37 
 a SD approximated by Ns = instead of calculated by BB BTBTs +++= , 
   as T, B, TB, and BB unavailable. 






Arm K Measuring System 
 
Water Phantom and Point Source Response Function 
 
One of the concerns in arm K measurement is the potential sensitivity of 
the system to arm volume.  To address this concern, the system was designed in a 
4p configuration to more efficiently capture the Compton scattered radiation 
caused by the K radiation transversing through the arm.  (Compton scattering is 
discussed previously in Chapter 2.1.2 and 2.1.3.)  Experiments with large and 
small 20gK water phantoms placed at the edge of the detector and at various 
points within the detection cavity were conducted to establish sensitivity.  
Detection regions outside and within the detection cavity are identified in the 
schematic of the interior side view of the PBK system (Fig. 4.1-2).  Within the 
main detection cavity (Region III) of the PBK system, the experiments confirmed 
a significant discrepancy present between large and small phantom net K peak 
counts for various distances within the detection cavity (Fig. 4.1-3).  The decrease 
in the large phantom net K peak counts as the phantom transverses the cavity is 
consistent with the volume loss as the phantom extends out of the detector region, 
and suggests possible self-shielding of K radiation emanating from the PMTs, 
prior to extension out of the detection cavity.  The increase of the small phantom 
net K peak counts for the same cavity locations, is similar to the increase mapped 
from a 9.1 gK point source (Fig. 4.1-4).   
Four regions outside and within the PBK system are designated in Fig. 
4.1-4.  In Fig. 4.1-4, Region I shows the average 80% decrease in response of the 
PBK system to the point source outside the PBK system relative to the response in 
the detector cavity (Region III).  Region II and IV in Fig. 4.1-4 shows the average 
36% decreased response of the PBK detectors to the point source when the point 
source is within the 10 cm front lead walls leading to the detector cavity (Region 





PMTs.  These results suggest a minimal or low contribution of K signal from 
Region I, II, and IV versus the stronger K signal directly measured in Region III. 
The distribution of the K in a water phantom versus as a point source and 
the diluting effect of the water phantom configuration on signal response is 
demonstrated in the lower values for average net K peak counts of a 10 gK large 
phantom (7000 net K peak counts) than the average value of the net K peak 
counts observed in Region III for the point source (8700 net K peak counts).  The 
greater number of total K Compton counts for the large phantom versus the small 
phantom, which is internally consistent, suggests the sensitivity of the PBK 
system to collecting a higher number of K Compton counts available from a 
larger sized phantom (Tables 4.1-2 and 4.1-3).  No significant change (i.e., greater 
than 1 s) is observed in the total tail ROI counts for either the small or large 
phantom versus a background spectrum (as demonstrated in the low or negative 
net tail ROI counts), confirming no background changes in the higher energy 
photon region above the K photopeak (Tables 4.1-2 and 4.1-3).  However, further, 
more in-depth calibration and characterization is needed to correlate arm 
potassium measure to arm volume. 
 
Phantom Assessment of the Attenuation Effect on K From Bone in the Arm 
 
The attenuation effect of bone on K peak counts from an arm was 
investigated by measuring large and small 20 gK water phantoms with inserted 
metals of two thicknesses, aluminum—0.95 and 1.90 cm, and iron—0.95 cm, of 
optical thickness similar to the natural range of a single bone thickness in the 
human arm (1 to 3.5 cm for the radius and ulna, individually).69  Optical thickness 




























   (4.1-1) 
 
where 1 and 2 are the bone and the investigated material, respectively, (µ/?) is the 
mass attenuation coefficient (cm2/g), ? is the density (g/cm3), and t is the thickness 
of the material or bone (cm).  For a 1.5 MeV photon energy, (µ/?) is 0.05 cm2/g, 
0.0487 cm2/g, and 0.054 cm2/g for aluminum, iron, and cortical bone, 
respectively.50  Bone density ranges from 1.7 to 2.0 g/cm3; an average value of 1.9 
g/cm3 was used.69   
A comparison of the ratio of net K peak counts from each 20 gK water 
phantom with rod material to a 20 gK water phantom with no rod material present 
(Table 4.1-4), indicates that bone thickness potentially has a reduction effect on 
the net K photopeak counts, approaching negligible in phantoms with thinner 
equivalent bone thicknesses (4% loss in net K peak counts, for 1.27 cm equivalent 
bone thickness), and being more pronounced with larger equivalent bone 
thicknesses (8% loss in net K peak counts, for 3.6 cm equivalent bone thickness).  
Although, originally, it was hypothesized that bone was a minimal effect, this 
experiment suggests that an average reduction of 5-10% of net K peak counts 
should be noted in arm potassium measurement, to account for average human 
arm bone thickness (4.5 cm).  With further, more extensive phantom calibration to 
refine assessment of systematic errors, this result may be within or in addition to 








Figure 4.1-2.  Interior side view of SLR PBK detection system. 






































Figure 4.1-3.  Net K peak counts from the small and large 20 gK water phantoms (WP) 
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Figure 4.1-4.  Response of the SLR system to a point source for the  
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Table 4.1-2.  Total counts in the regions of interest, K Compton, K peak, and tail for 20 gK water phantoms 










































30 cm vs. 
10 cm 
Ratio 











10 66693 ± 258 19400±139 7495±87 0.29 2.6 S 







10 70058 ± 265 20176±142 7550±87 0.29 2.7 L 














Table 4.1-3.  Net counts in the regions of interest, K Compton, K peak, and tail, for 20 gK water phantoms at 









Net K Compton 
Counts 





30 cm vs. 
10 cm 
Ratio 
Net K Peak 
Counts 
± SD (counts)b 
Net K Peak 
Counts at 





± SD (counts)c 
Net Tail 
Counts at 
30 cm vs. 
10 cm 
Ratio  
10 21927 ± 334 13657 ± 159 -63 ± 123 S 
30 24240 ± 337 
1.11 
16356 ± 167 
1.20 
-132 ± 122 
1a 
10 25292 ± 339 14433 ± 161 -8 ± 123 L 
30 22910 ± 335 
0.91 
12112 ± 154 
0.84 
76 ± 123 
(76)b 









Table 4.1-4.  Simulation of bone with various materials within a large 
20 gK water phantom (WP).  Measurement for 15 min. 
 
 






Net K Peak 
Counts 
± SD (counts) 
Ratio of Net K 
Peak Counts 
from WP & 
Rod vs. WP 
0 0 14386 ± 161 0.0 
Al—0.95 1.27 13766 ± 159 0.96 
Al—1.90 2.54 13366 ± 158 0.93 







4.2. Detector Assessment: Sensitivity and MDL 
 
Brain K Measuring System 
 
To assess the sensitivity and MDL when measuring K in the brain using a 
single or multiple detector system, initially, two types of scintillation detectors 
were investigated, a high purity germanium (HP-Ge) detector and NaI(Tl) 
detectors of various sizes.  The various detectors were evaluated by sensitivity 
and MDL to determine which type and size detector would be best for assessing 
brain K.  The detectors were evaluated separately using a 4 gK water phantom 
and a 4 gK point source at various distances from the detector, for a counting time 
of 1 hour, the same amount of time chosen for clinical measurement.  Sensitivity, 
S/N, and MDL were calculated using the equations defined in Chapter 2.1.5, with 
the MDL values expressed in gK (for water phantom measurements) and in 
counts for point source measurements. 
Using the TM, the results of the response of the various detectors to source 
distribution and positioning, are summarized in Table 4.2-1.  For the various 
measurement configurations, differing in positioning and distribution, the trends 
in the results are internally consistent.  For greater distances from the detector, the 
net counts were less, and the net counts were larger for the K point source than 
the spatially distributed K in the water phantoms.  The net counts significantly 
decreased for the smaller NaI sizes, although the MDL was about the same.   
Low counting statistics is the driving factor in the large uncertainties, 
about 15%, in the water phantom measurements, using the 3”x3” NaI detector.  
Furthermore, a similar relative uncertainty of 20% was found for the 10% 
efficient HP-Ge detector, in spite of the extremely low counting statistics (37 
counts) of the HP-Ge due to the considerably reduced background of six counts.  





for the low counts from the HP-Ge, this method was used with the NaI(Tl) and 
HP-Ge detectors in order to compare the two detector types with a single 
methodology.  Using the TM, the similar uncertainties with the 3”x3” NaI(Tl) and 
the HP-Ge suggest that of the two detector types, the NaI(Tl) type is preferred for 
a multiple detection system, because of higher counting statistics and a significant 
reduction in cost. 
Examining other aspects of the data (Table 4.2-1), revealed that although 
the sensitivity varied considerably for the different detector types and sizes, 
changes in S/N and MDL are rather small.  Therefore, this results suggests that 
any improvement in the design of the multiple detector system will be based on 
maximizing sensitivity, and reducing the ambient room background, rather than 
changes in MDL or S/N.  Statistical error reduction will be addressed further 






Table 4.2-1. Results of K analysis using various detection systems from a 4 gK water phantom (WP) and 4 gK point 




















Net K Counts 










NaI(Tl)a  3"x3" 
WP at surface 
620 ± 25 277 ± 17 343 ± 30 108 ± 16 235 ± 35 59 14 0.6 
NaI(Tl)b  3"x3" 
WP at 1" away 
563 ± 24 286 ± 17 277 ± 29 108 ± 16 169 ± 37 42 10 1.0 
HP-Gea  10% 
WP at surface 47 ± 7 6 ± 2 41 ± 7 4 ± 2 37 ± 8 9 15 0.4 
NaI(Tl)c  3"x3" 
PS at surface 2074 ± 45 573 ± 24 1501 ± 51 108 ± 16 1393 ± 55 348 58 (72)
g 
NaI(Tl)d  3"x3" 
PS at 1" away 930 ± 31 313 ± 18 617 ± 35 108 ± 16 509 ± 41 127 29 (53) 
NaI(Tl)d  2"x6" 
PS at 1" away 
479 ± 22 247 ± 16 232 ± 27 60 ± 8f 172 ± 33 43 11 (47) 
NaI(Tl)d  2"x3" 
PS at 1" away 
356 ± 19 204 ± 14 152 ± 24 48 ± 7f 104 ± 28 26 7 (43) 
a Water phantom (WP) placed at the surface of a shielded detector; b Water phantom placed 1" away from the surface of the detector. 
c Point source (PS) placed at the surface of the detector; d Point source placed 1” away from the surface of the detector. 
e Uncertainty in the Net K counts according to BB BTBTs +++= ; 
f  SD approximated by Ns =  instead of calculated by BTs += , 





Prototype Four 5”x3” NaI(Tl) Brain K Detector System 
 
Initial assessments of a four 5”x3” NaI(Tl) detector system for measuring 
K in the brain were evaluated using the small 0.0 gK and 10.0 gK water phantoms 
described in Chapter 3.2.  Using the TM for analysis, the prototype four 5”x3” 
NaI(Tl) detector system was compared to the single 3”x3” NaI(Tl) Brain K 
Measuring System.  For the prototype four 5”x3” NaI(Tl) detection system, the 
net K peak counts increased by a factor of 12 for ambient room background, and a 
factor of 10 for a small 10 gK water phantom when compared with the single 
3”x3” NaI(Tl) Brain K Measuring System (Table 4.2-2).  The increase in factor 
was directly related to the increase in detector volume, as shown by comparing 
the ratio of the entire spectral area to the ratio of volume from the single 3”x3” 
NaI(Tl) Brain K Measuring System, a single 5”x3” NaI(Tl), and the prototype 
four 5”x3” NaI(Tl) detector system (Table 4.2-3).   
Examining the ratio of the total counts in three specified regions of interest 
(ROI) (K Compton, K peak, and tail), for the single 5”x3” NaI(Tl) detector as 
compared to the single 3”x3”NaI(Tl) detector for a 10 gK water phantom yields a 
moderate variation (within 2 s) for the three ROIs, with a ratio of 3.1, 2.6, and 
4.4, respectively, for each ROI individually (Table 4.2-4).  Comparing by ratio, 
the prototype four 5”x3” NaI(Tl) detector system to the 3”x3”NaI(Tl) detector 
system for each ROI, yields a slightly larger variation between the three ROIs 
(within 3 s)  with a ratio of 12.8, 8.9, and 15.5, respectively (Table 4.2-4).  The 
higher total counts in the K Compton and tail regions of interest for the four 
5”x3” NaI(Tl) detector system as compared to the single 5”x3” NaI(Tl) is 
explained by the four 5”x3” NaI(Tl) detector system’s larger overall detector 
volume and the greater efficiency of multiple detectors to detecting Compton 
scattering interactions and higher energy photons.  Evaluating the individual 





Net K peak counts varied with distance from the K source (i.e., a water phantom), 
and were internally consistent. 
Initial results using the single 3”x3” NaI(Tl) Brain K Measuring System, 
discussed in the previous section, indicate that the lowest MDL possible with the 
single 3”x3” NaI(Tl) Brain K Measuring system was 0.6 gK/hr, and a sensitivity 
of 59 c/g/hr.  Using the same small 0.0 gK and 10.0 gK water phantoms as with 
the single 3”x3” NaI system, to calibrate the prototype four 5”x3” NaI(Tl)  
detector system, the MDL and sensitivity of the four 5”x3” NaI(Tl) detector 
system was ascertained to be 0.3 gK/hr (using Eq. 2.4-2 with TM analysis) and 
452 c/g/hr, respectively.   Therefore, for the four 5”x3” NaI system as compared 
to the single 3”x3” NaI, the MDL decreased by a factor of 2 and the sensitivity 







Table 4.2-2.  Comparison of the net K peak counts (± SD in counts) for the single 3”x3” NaI(Tl) Brain K 
Measuring System, a single 5”x3” NaI(Tl) detector system, and a prototype four 5”x3” 
































Background 167 ± 27 335 ± 46 2008 ± 96 12 6 
0 gK 113 ± 26 318 ± 46 1853 ± 96 16 6 








Table 4.2-3. Comparison of detection volume ratios with the measured 
spectral areas for the single 3”x3” NaI(Tl) Brain K Measuring System, a 




Detector Size (V inch3) Volume Ratio Spectral Area 
Ratio 
Single 3”x3”  (21) 1 1 
Single 5”x3”  (59) 2.8 3.3 







Table 4.2-4.  Counts in the K Compton, K peak, and tail regions of interest (ROI) for the single 3”x3” NaI(Tl) Brain 
K Measuring System, a single 5”x3” NaI(Tl) detector system, and a prototype four 5”x3” NaI(Tl) detector system.  















K Peak  
Counts 













± SD (%) 














± SD (%) 
Ambient 
Background 
13636 ± 1 430 ± 5 258 ± 6 172 ± 15 -- 668 ± 4 0.03 0.6 14734 ± 1 
Ambient 
Background 
13493 ± 1 442 ± 5 286 ± 6 156 ± 17 -- 746 ± 4 0.03 0.6 14681 ± 1 
Ambient 
Backgrounda 
13615 ± 1 444 ± 5 277 ± 6 167 ± 16 -- 710 ± 4 0.03 0.6 14768 ± 1 
0 12181 ± 1 392 ± 5 279 ± 6 113 ± 23 0 ± 23 711 ± 4 0.03 0.6 13284 ± 1 
Single 
3”x3” 
10 15383 ± 1 1178 ± 3 517 ± 4 661 ± 66 548 ± 9 697 ± 4 0.08 1.7 17258 ± 1 
Ambient 
Background 
41212 ± 0.5 1212 ± 3 877 ± 3 335 ± 14 -- 3035 ± 2 0.03 0.4 45459 ± 0.5 
0 42941 ± 0.5 1216 ± 3 898 ± 3 318 ± 15 0 ± 15 3011 ± 2 0.03 0.4 47168 ± 0.5 




10 48108 ± 0.5 3039 ± 2 1068 ± 3 1971 ± 3 1653 ± 5 3045 ± 2 0.06 1.0 54187 ± 0.4 
Ambient 
Background 
176676 ± 0.2 5564 ± 1 3556 ± 2 2008 ± 5 -- 10682 ± 1 0.03 0.5 192922 ± 0.2 
Ambient 
Background b 
178152 ± 0.2 5543 ± 1 3625 ± 2 1918 ± 5 -- 10949 ± 1 0.03 0.5 194643 ± 0.2 
0 182071 ± 0.2 5505 ± 1 3652 ± 2 1853 ± 5 0 ± 5 11295 ± 1 0.03 0.5 198871 ± 0.2 
0b 181530 ± 0.2 5597 ± 1 3787 ± 2 1811 ± 5 -- 10916 ± 1 0.03 0.5 198043 ± 0.2 
10 196540 ± 0.2 10731 ± 1 4359 ± 2 6372 ± 2 4519 ± 3 10867 ± 1 0.06 1.0 218138 ± 0.2 
Four 
5”x3” 
10b 196752 ± 0.2 10578 ± 1 4466 ± 2 6113 ± 2 4260 ± 4 10834 ± 1 0.05 1.0 218164 ± 0.2 
aConverted from 18 hr measurement. 






Comparison of Statistical Error Propagation Using TM and LLS Methods 
For the Brain K Measuring System versus Prototype Four 5”x3” Brain K 
Detector System  
 
To ascertain the uncertainty in spectra with gK values approaching the 
MDL for the four 5”x3” NaI system, simulations of one-hour 1 gK and 0.5 gK 
spectra created from 12-hr measured spectra were analyzed (Table 4.2-5).  
(Methodology on synthetic spectra generation and spectral analysis by the TM 
and LLS methods is discussed in detail in Chapter 5.)  Comparing Table 4.2-5 for 
the prototype four 5”x3” NaI(Tl) detector system with Table 5.3.2-1 for the single 
3”x3” NaI(Tl) Brain K Measuring System, the statistical error reduced 
considerably for the TM method, by a factor of 1000, for both gK cases.  For the 
LLS method, the statistical error reduced by a factor of 1.8 and a factor of 3, 
respectively.  With the significant statistical error reduction, the results of these 
two simulated cases support the premise that values approaching the MDL are 
measurable with a multi-detector NaI system.  However, with the large percent 
difference of 120% and 40% for the 0.5 gK case using the TM method and LLS 
method, respectively, maximizing the K signal through additional shielding, 





Table 4.2-5.  0.5 and 1.0 gK synthetic spectra analyzed for a prototype four 5”x3” NaI(Tl) 
detector  system and the ratios of the calculated to nominal intensities compared 
for the TM and LLS methods . 
 









± SD (%) 
Calculated 
K (g) 




± SD (%) 
Reduced 
?2 
1 1.2 ± 4 1.2 ± 4 1.1 ± 13 1.1 ± 13 0.94 
0.5 1.1 ± 4 2.2 ± 4 0.3 ± 42 0.7 ± 42 0.93 























5. Evaluation of Numerical Techniques to Determine PBK 
 
5.1. Overview of Investigations 57 
 
The challenge to measure partial body K in the brain is its extremely weak 
signal due to the small amount of K present in the brain, about 4 g, and the very 
small percentage of 
40
K (0.0112%) relative to K, resulting in a K signal with very 
low counting statistics.  To address the low counting statistics, with intention to 
improve the assessment of K in the brain, two approaches for spectral analysis; 
the Trapezoidal method (TM), and the Library Least-Squares (LLS) method were 
evaluated.  (The Stripping Method was briefly assessed with the Trapezoidal 
Method to compare photopeak analysis to whole spectra analysis.)  For that 
purpose, synthetic spectra based on measured spectra using the BNL Brain K 
Measuring System and the brain water phantoms (described in Chapter 3.2) were 
analyzed using both methods.  Ratios of calculated to nominal gK values were 
used to compare the two methods and their statistical error propagations.  In 
addition, additional aspects of the LLS method were evaluated using multi- fold 
background spectra, mono- library analysis, and gain shifted spectra.  In either 
case, all analyses were conducted on the BNL Brain K Measuring System spectra 





5.2. Trapezoidal Method versus Stripping Method57 
 
Water phantoms containing 4 gK, representing the brain, were used to 
evaluate the these two methods of analysis.  When using the Stripping Method, as 
compared to the Trapezoidal Method, for Compton Continuum background 
evaluation under the K photopeak region, the results show reduced statistical error 
due to improved counting statistics, from 15% to 9%, for the 4 gK water phantom 
case.  The K signal, S, defined as the number of net K counts in the residual 
spectrum from the stripping method when compared to the K signal determined 
by the net K counts in the K photopeak region from the TM improves the K signal 
by a factor of 6.4.  The noise, N, defined as the square root of the background for 
the same two regions, increased by a factor of 4.6 for the stripping method.  
Therefore, the increase in K signal than noise was greater for the stripping method 
than the TM, and the improvement in the reduction of statistical error in the net K 
counts using the stripping method as compared to the trapezoidal method, 
supports using the entire spectrum rather than the K photopeak in further analysis.  
Thus, a comparison of the Trapezoidal Method and the Library Least-Squares 






5.3. Trapezoidal Method Versus Library Least-Squares Method 
 




The LLS method equations described in Chapter 2.2.3, were solved using 
a FORTRAN 77 program, listed in Appendix A.1.  The output consisted of xj 
library fractions with standard deviations for each library selected for a given 
case, reduced χ2 values, and a list of relative residuals for each channel in the 
selected spectral region for the applied LLS method.  
 
Presentation of Libraries57 
 
The BNL Brain K Measurement System and the 10 gK small brain water 
phantom, described in Chapter 3, were used to acquire two spectra, respectively, a 
ambient room background K spectrum (with no phantom present) and a 10gK 
water phantom spectrum, both measured for 18 hours to obtain good statistics.  
These two spectra were then used to generate two library reference spectra for the 
LLS method, referred to as Ambient Room Background (abbreviated as “Bckg” 
or “Background”) and K Libraries.  (The library data is listed in Appendix A.2.)  
The pure K reference library was derived using high statistics measurements in 
which the tail of the ambient room background spectrum, the part of the spectrum 
above the K photopeak, was least-squares fitted to the tail of the 10 gK spectrum.  
This least-squares fitted ambient room background then was subtracted in its 
entirety from the 10 gK spectrum, resulting in a pure K library.  The resulting 





references for spectral deconvolution, as well as for quantitative analysis using the 

























Figure 5.3.1-1.  The Ambient Room Background (Bckg) and K library 







To demonstrate various advantages of the LLS method for spectra 
analysis, the spectra were simulated instead of measured, and scaled down to the 
equivalent of a one-hour measurement.  The synthetic spectra were generated by 
adjusting the measured library standards by a desired factor xj, and then varying 
the number of counts in each channel according to a random normally distributed 
variate with a standard deviation corresponding to the square root of the number 
of counts in each channel.  (This was accomplished through a modification of the 
LLS FORTRAN program listed in Appendix A.1, with a standard random number 
generator program for normally distribution values applied [program not listed].)  
Thus, the two created spectra, one for ambient room background and one for a 
specified amount of K in a water phantom, were combined into a simulated 
spectrum of an amount of gK in a water phantom with the associated ambient 
room background that was analyzed by the TM and the LLS methods.  These 
simulated synthetic spectra with 0.1, 0.5, 1, 5, and 10 gK, shown in Fig. 5.3.1-2 
(with 0.5 gK omitted for clarity) were analyzed for statistical error propagation 
using each analytical method.  The calibration line shown in Fig. 3.3.2-1 was used 
in determining K content in grams in the simulated K spectra for the TM.  The 
effect of variations in the background counts for the same K concentration, the 
effect on statistical error propagation of a missing library spectrum in the LLS 
analysis, and the effect of gain and zero shift in the spectrum also were 
investigated. Since normal statistics were imposed on the derived library spectra 
no correlation was observed in the residual spectra following analysis of the 
































Synthetic spectra for various K concentrations were analyzed using the 
TM method (Chapter 2.2.1) and the LLS method (Chapter 2.2.3).  For the TM 
method, the calculated net K counts in the K peak was adjusted for the 
contribution of the K present in the background, NKB = 147 ± 13%, which 
increased the statistical error propagation (as described in Chapter 2.2.1).  The net 
number of counts in the K peak was converted to gK, using the calibration line in 
Fig. 3.3.2-1.  At concentrations equal to or greater than 1 gK, the statistical errors 
varied from 57 to 8%  (Table 5.3.2-1).  The total uncertainty in the net K counts 
was calculated using Eq. 2.2.1-4, with the uncertainty in the calibration line 
considered negligible in this case.  For the LLS method, the fitted intensities, xj, 
for the K library were converted to gK by multiplying them by 180 (18 hr and 10 
gK).  For all K concentrations, the standard deviation of the xBackground, remained 
1%.  The reduced ?2 values, indicative of the goodness of fit, remained close to 
1.0 for all cases.  Evaluating the ratios between the calculated concentrations and 
the nominal values for each method; for all K concentrations, the uncertainty in 








Table 5.3.2-1.  One-hour synthetic spectra analyzed and a comparison of the ratios of the calculated 
to nominal intensities for the TM and LLS methods .57 
 









± SD (%) 
Calculated 
K (g) 




± SD (%) 
Reduced 
?2 
10 10.7  ±  8 1.07  ± 8 9.6 ± 4 0.96  ± 4 0.93 
5 5.6  ±  13 1.13  ± 13 4.8 ± 6 0.95  ± 6 0.87 
1 1.1  ±  57 1.14  ± 57 1.0 ± 24 1.01 ± 24 0.89 
0.5 ~0 ± 3926 -0.70  ± 3926 0.2 ± 126 0.38 ± 126 1.04 
0.1 ~0 ± 3834 -2.5  ± 3834 -0.2 ± 141 -1.98 ± 141 1.49 























Multi-fold Background Simulations 57 
 
Increased background conditions on the spectral analysis and statistical 
error propagation were also investigated using one-hour 1, 5, and 10 gK synthetic 
spectra with a two- and ten-fold increased background.  An example of the 10 gK 
spectra with increased background are shown in Fig. 5.3.2-1.  Analysis of the 
increased background, resolved the background with an uncertainty of 1% or less, 
and 0.3% for the ten-fold case (Table 5.3.2-2).  For all K concentrations, the LLS 
method yielded statistical propagation errors that were consistently smaller than 
those resulting from the TM method (with the exception of the 1 gK with ten-fold 
background case), and the resolution of the LLS method was greater than the TM 
method, with 16% standard deviation or less, for the 5 gK and 10 gK 
concentrations with the ten-fold increased background (Table 5.3.2-3).  In the 1 
gK case with normal background, the LLS method had a smaller statistical 
propagation error and smaller percent difference in comparing calculated gK to 
nominal gK.  However, for the 1 gK case with two fold background, the TM 
method had a smaller percent difference between calculated and nominal gK than 
the LLS method.  This may be attributed to the slightly higher MDL when using 
the LLS method.  Nevertheless, neither method satisfactorily resolved the 
spectrum for 1 gK with the ten-fold increased background, as the counts were 






















Figure 5.3.2-1. Synthetic spectra of 10 gK with two - and ten-fold 






Table 5.3.2-2.  Fitted Ambient Room Background library component 
(xBackground) from LLS analysis of 1, 5, and 10 gK/hr synthesized 


















± SD (%) 
Normal 0.056 0.055 ± 1 0.996 ± 1 
Two fold 0.11 0.11  ±  1 0.998 ± 1 
Ten fold 
10 
0.56 0.55 ± 0.3 0.995 ± 0.3 
Normal 0.056 0.056 ± 1 1.00 ± 1 
Two fold 0.11 0.11  ±  1 1.00 ± 1 
Ten fold 
5 
0.56 0.56 ± 0.3 1.00 ± 0.3 
Normal 0.056 0.056 ±  1 1.00 ± 1 
Two fold 0.11 0.11  ±   1 0.998 ± 1 
Ten fold 
1 







Table 5.3.2-3.  TM and LLS analysis of 1, 5, and 10 gK/hr synthesized with two- and ten-fold 






Net K Peak 
Counts 
± SD (%) 
Calculated 
gK 
± SD (%) 
Fitted xK 
± SD (%) 
Calculated 
gK 
± SD (%) 
Normal 641 ± 8 10.9 ± 8 0.053  ± 4 9.6 ± 4 
Two fold 647 ± 10a 11.0 ± 10 0.054 ± 4 9.7 ± 4 
Ten fold 
10 
663 ± 19b 11.3 ± 19 0.058 ± 8 10.4 ± 8 
Normal 337 ± 13 5.7 ± 13 0.026 ± 6 4.8 ± 6 
Two fold 296 ± 20c 5.0 ± 20 0.026 ± 9 4.6 ± 9 
Ten fold 
5 
338 ± 36d 5.8 ± 36 0.025 ± 16 4.6 ± 16 
Normal 69 ± 66 1.2 ± 66 0.0056  ± 24 1.0 ± 24 
Two fold 58 ± 94e 1.0 ± 94 0.0021 ± 91 0.4 ± 91 
Ten fold 
1 
48 ± 254f 0.8 ± 254 -0.0016 ± 274 -0.3 ± 274 
   a NB = 350 ± 11%  c NB = 274 ± 14%  e NB = 285 ± 14% 






5.3.3. LLS Method Aspects57 
 
There are several advantages of the LLS method.  For one, it offers the 
possibility to analyze the residual spectra and to perform iterative gain and zero 
shifts corrections in the measured spectra.  The residual spectrum is defined as the 
difference between the measured spectrum and the fitted library standards.  
Second, when the fit is good, the residual spectrum in units of standard deviations 
(SD) will be randomly distributed between ± 3 to ± 4 SD, and the reduced χ2 
should approach a value of one.  (A discussion of χ2and reduced χ2 is found in 
Chapter 2.2.3.1.)  However, if one of the libraries is missing or there are any 
spectral distortions that cause the measured spectrum to differ from the linear 
superposition of the standard libraries, the residual spectrum will manifest a 
structure that is not randomly distributed, and should be further inspected.   
 
Single Library Analysis57 
 
The ability of the LLS method to resolve a missing library, was assessed 
by analyzing the previous synthetic spectra with a missing K standard (Table 
5.3.3-1).  The reduced ?2 values increased for each simulated spectra of 1 gK or 
higher, as compared to the two-library LLS analysis (Table 5.3.2-1).  Differences 
greater than 3 s were also apparent in the residual spectrum for 5 and 10 gK.  The 






Table 5.3.3-1.  LLS analysis on synthetic spectra with single library 
(Ambient Room Background library).57 
 







± SD (%)a 
Reduced 
?2 





10 0.056 0.065  ±  1.4 3.64 1.17 
5 0.056 0.061  ±  1.0 1.76 1.09 
1 0.056 0.057 ±  0.79 0.95 1.02 
0.5 0.056 0.055 ±  0.84 1.04 0.99 
0.1 0.056 0.054   ±  1.0 1.48 0.98 

























Figure 5.3.3-1.  Relative residuals from the analysis of a 5 gK synthetic 







Gain and Zero Shift Correction Analysis57 
 
Gain and zero shifts may occur due to electronic instabilities or other 
variations in the system.  In these cases, the distorted spectrum can be iteratively 
corrected until the reduced ?2 is minimized.  The correction is based on the fact 
that the total number of photons arriving at the detector is independent of the 
detection system and the associated electronics set up.  This can be expressed as 
an integral equating the areas under the curves before and after the gain and zero 
shifts 
 








')'(')(    (5.3.3-1) 
   
where the standard spectrum is denoted by F’(E’), the shifted spectrum as F(E), 
and E is the incident photon energy.  Equation 5.3.3-1 has to be expressed in 
discrete terms of the measured pulse height instead of the continuous incident 
photon energy.  Using Eq. 5.3.3-1 and substituting energy E and E’ with the 
energy calibration lines for each spectrum (standard spectra of AxkE += ''' , and 
shifted spectra of BkxE += ), the newly calculated spectrum f in channel i is 































   (5.3.3-2) 
 
where f is in counts per unit energy, and ß is the ratio of the calibration line 
slopes.  Although offset ‘A’ might be equal to offset ‘B’ or both might be 0 at 





To illustrate this procedure, a spectrum that was acquired with a two-fold 
reduced gain relative to the libraries, was subsequently readjusted using gain and 
zero shift corrections according to Eq. 5.3.3-2 is shown in Fig. 5.3.3-2.  The 





















Figure 5.3.3-2.  Shifted and corrected 0 gK spectra for 1 hr using gain 
shift correction.  Ambient room background (Bckg) library spectrum 








6.  Clinical Results For PBK 
 
Volunteers and patient s were measured with two different partial body K 
systems, after calibration and characterization of the systems, as discussed in 
Chapters 3 and 4.  The BNL system was used to measure brain K in five healthy 
volunteers and the SLR system was used to measure K in the arm of 56 healthy, 
aged, or CRF-disease subjects.  The TM and LLS methods were used to analyze 
the BNL data and the Stripping Method was used for the SLR system.  The 
various results are summarized below.  
 




To demonstrate the validity of the Brain K Measuring System, five 
volunteers were measured, consisting of three males varying in age from 23-59 
and two females, varying from age 27-29.  The males were, on average, older than 
the females and all gave written informed consent confirming a negative medical 
or surgical history.  The study was approved by the BNL Institutional Review 
Board (IRB Protocol #378).  Subjects were measured in street clothes laying on a 
medical bed (shown in Fig. 3.1-1.) with the top of their heads positioned next to 
the NaI detector for one hour (Fig. 6.1-1).  Single background measurements for 
one hour were taken immediately prior to subject measurements #1 and #2, and 
two background measurements were taken, prior and after subject measurements 

















The analysis results of the five Brain K Measuring System volunteers 
analyzed using the TM and the LLS methods are summarized in Table 6.1-1.  The 
LLS method yielded systematically higher results than the TM method by up to 
30%.  However, a cohort of five volunteers is too small to give any definitive 
explanation of this effect, if real.  Nevertheless, as expected, the statistical 
uncertainty associated with the LLS method was consistently smaller than that for 
the TM method.  Furthermore, the slightly high reduced ?2 (greater than one) from 
the LLS method for subjects #2, 4, and 5 indicated, as expected, the lesser good 
fit with the libraries, that for these Brain K measurements was caused by small 
gain shift corrections.   
The analysis results demonstrate satisfactorily the viability of the method 
to measure K in the human brain, and using a calibration based on the water 
phantoms, provide similar brain K values to those given in the ICRP Report of the 
Task Group on Reference Man (4.2 gK, error bars not given).17  In addition, the 
volunteer data also reflects the disparity of potassium content present in male and 
female brains, through the lower K values for the female subjects.  The lower 
brain K value for females is predicted, from the Reference Man brain K value 
when adjusted for the smaller volume of brain mass in the human female (1.2 L) 
as given for Reference Woman, and when the same gK/cc ratio is assumed, giving 










†M: Male; ‡ F: Female 
 aBackground measurements taken prior and after subject measure and averaged where noted. 






























Net K Counts 








± SD (%) 
Grams  
K 
± SD (%) 
Reduced 
?2 
1 (M)† 729 ± 27 340 ± 18 388 ± 33 131 ± 25 257 ± 41 4.3 ± 16 4.94 ± 5 0.8 
2 (M) 785 ± 28 328 ± 18 457 ± 33 177 ± 27a 280 ± 43 4.7 ± 15 4.22 ± 9 1.7 
3 (M) 777 ± 28 340 ± 18 437 ± 33 178 ± 27 259 ± 43 4.3 ± 17 5.29 ± 6 1.2 
4 (F)‡ 735 ± 27 377 ± 19 358 ± 33 166 ± 15a 192 ± 37 3.2 ± 19 4.13 ± 8 1.6 





6.2.  Arm K Subject Measurements 
 
Participants and Method 
 
Potassium in the lower and part of the upper arms in 73 adult volunteers 
were measured using the SLR Arm K Measuring System.  Volunteers were 
collected by St. Luke’s Hospital from three different studies approved by the 
Institutional Review Board of St. Luke’s/Roosevelt Hospital Center and organized 
into three cohorts: 1) normal healthy adults [N], up to 61 years of age, 2) elderly 
(aging) healthy adults [A], above 62 years of age, and 3) adults with chronic renal 
failure (CRF) disease on hemodialysis, [HD], 33-73 years of age.  The subjects, in 
addition to PBK measurements of the arm, underwent twelve standard body 
composition measurements at St. Luke’s Hospital that included TBK, dual energy 
x-ray absorptiometry (DXA), eight anthropomorphic measures (weight, height, 
upper and lower arm circumference, upper and lower arm length, and upper and 
lower arm skinfold), extracellular water (ECW) by bromine dilution, and total 
body water (TBW) by 2H2O dilution.  The data from the body composition 
measurements, except PBK, was provided from a database compiled by St. 
Luke’s Hospital.  The raw spectral data for PBK and the anthropomorphic 
measures, except weight and height, were collected by medical technicians trained 
in PBK statistical analysis method by the author.  Not all subjects underwent all 
of these different body composition measurements; the number of volunteers 
measured using each of the methods are listed in Table 6.2-1.  From these 
measurements, three additional indices were calculated using standard formulas 
based on body composition relationships, including body mass index (BMI), 
intracellular water (ICW), and arm DXA lean soft tissue.  BMI was calculated 
using the formula4 
 





BMI values ranging from 19-29 kg/m2 are considered healthy, 30 kg/m2 and 
above defined as clinically obese.4,71 ICW was derived from the difference of 
TBW and ECW.4,68  Arm DXA lean soft tissue was derived from the difference of 
measured arm DXA soft tissue and measured arm DXA fat.4,71   
Two statistical methods were used to assess the correlations between PBK 
and the standard body composition indices.  These methods were also used to 
assess the correlations between the standard TBK and the other body composition 
indices, in order to contrast the correlations of PBK with the body composition 
indices to the correlations of TBK with the same indices.  The assessment of PBK 
and TBK with the indices were between same cohorts, Normal, Aging, or 
Hemodialysis.  The first analytical method, regression analysis (described in 
Chapter 2.2.2.1), was applied to test whether PBK and TBK measures were in 
linear relationships with the various body composition indices.  A high r2 value 
indicates a strong linear relationship between PBK or TBK with the indices.  The 
p-value for each correlation was assessed through an applied t-test for two 
independent samples (Chapter 2.2.2.1).  Second, a beta statistics test was applied 
to each correlation comparison.  The beta statistics test applied the linear equation 
y = ax, generated by each regression analysis on PBK or TBK with the index, to 
the data and generated the probability of fit with the linear equation. 72  Probability 
between 0.5 and 0.95 was considered a good fit.72  In cases of poor fit, an 
additional beta statistic test with the regression linear equation of the form y = ax 
± b was also applied and the probability observed. 
Another statistical method, ANOVA, was applied to compare the PBK 
values according to cohort (Chapter 2.2.2.1).  The p-values generated for each 
PBK cohort comparison was contrasted with the TBK cohort comparison p-
values.  Additionally, the 73 PBK cohort comparison p-values were contrasted 








6.2.1.  Statistical Analysis Results 
 
Significant Correlations Using Regression Analysis 
 
Significant correlations (r2 = 0.7) were found between PBK with TBK, 
PBK with ICW, PBK with arm DXA lean soft tissue, PBK with arm DXA fat, and 
PBK with upper arm skinfold.  The regression parameters for the strongest 
correlations are summarized in Table 6.2.1-1.  The regression parameters for TBK 
with ICW, TBK with arm DXA lean soft tissue, TBK with arm DXA fat, and 
TBK with upper arm skinfold are listed in Table 6.2.1-2.  The regression 
parameters were used to investigate the similarity in the strong correlations of 
PBK versus these body composition indices to TBK with the same body 
composition indices. 
 
Significant Correlations Using Beta Statistics 
 
Mean values of standard deviation (coefficients of variation [CV]) for the 
five significant correlated body composition indices were applied in the beta 
statistics test: TBK (1.5%), ICW (4.8%, a combination of standard deviation of 
TBW (2.1%) and ECW (2.7%)), arm DXA lean soft tissue (4%, a combination of 
standard deviation of arm DXA soft tissue (1%) and arm DXA fat (3%)), and 
upper arm skinfold (34.9%).73,74,75,76  For PBK, the mean value of standard 
deviation was 5.5%.  However, for the PBK index only, the standard deviation for 
each individual measurement, calculated through the method stated in Chapter 
2.2.2, was used with the beta statistics test.  Of the five significant correlations 
between PBK and the body composition indices using regression analysis, PBK 





(Table 6.2.1-3).   Additionally, the significance was valid for each cohort in this 
comparison.  A summary of the beta values and probabilities for each comparison 
are listed in Tables 6.2.1-3 and 6.2.1-4.   
However, for strong correlations between TBK and the body composition 
indices (Table 6.2.1-2), beta statistics analysis failed (Table 6.2.1-4).  Beta 
statistics analysis was reapplied to the strongest TBK regression analysis 
correlations using the maximum standard deviation for TBK reported in the 
literature, 5% (Tables 6.2.1-5 and 6.2.1-6).  However, the larger error bars did not 
improve any probabilities to a significance level, except the correlation between 
TBK versus ICW for the normal cohort.  Therefore, the conclusion may be that 
there is a rough correlation between these indices, but the difference between the 
indices is not explained entirely by experimental uncertainty values.  This further 
suggests that: 
1) That other factors, statistical or clinical, may be involved in this 
relationship  
2) The reported correlation may not be a linear relationship and may be 
better represented by a non- linear model 
3) The error reported in the literature under-represents the true error in the 
index. 
Potential clinical explanations of the failures of the beta statistics test are 










PBK Versus  n r2 p 
TBK-Na 10 0.72 0.002 
TBK-Ab 13 0.52 0.005 
TBK-HDc 21 0.51 0.0003 
ICW-N 7 0.85 0.003 
ICW-A 11 0.45 0.02 








12 0.72 0.0005 
Arm DXA 
Fat-N 
7 (-) 0.76 0.01 
Arm DXA 
Fat-A 
12 (-) 0.048 0.5 
Upper Arm 
Skinfold-N 
36 (-) 0.0032 0.7 
Upper Arm 
Skinfold-A 
19 (-) 0.0002 0.95 
Upper Arm 
Skinfold-HD 
21 (-) 0.62 0.00002 





Table 6.2.1-2.  Regression parameters from TBK versus standard body 
composition indices. 
 
TBK Versus  n r2 
ICW-N 7 0.97 
ICW-A 10 0.84 











7 (-) 0.54 
Arm DXA 
Fat-A 
10 (-) 0.034 
Upper Arm 
Skinfold-N 
9 (-) 0.26 
Upper Arm 
Skinfold-A 
13 (-) 0.12 
Upper Arm 
Skinfold-HD 
21 (-) 0.26 






Table 6.2.1-3.  Beta values and probability of fit for PBK versus  
standard body composition indices. 
 
PBK Versus  n Beta Probability 
TBK-Na 10 6.22 0.72 
TBK-Ab 13 8.07 0.78 
TBK-HDc 21 26.54 0.15 
ICW-N 7 8.78 0.19 
ICW-A 11 967 2 E-201 








12 0.0022 1.00 
Arm DXA 
Fat-N 
7 0.31 0.99 
Arm DXA 
Fat-A 
12 0.066 1.00 
Upper Arm 
Skinfold-N 
36 77.90 4.2 E-05 
Upper Arm 
Skinfold-A 
19 0.0022 1.00 
Upper Arm 
Skinfold-HD 
21 80.60 3.1 E-9 







Table 6.2.1-4.  Beta values and probability of fit for TBK (± SD of 1.5%) 
versus standard body composition indices. 
 
TBK Versus  n Beta Probability 
ICW-N 7 56.04 3 E-10 
ICW-A 11 50.07 1 E-7 








12 1.23 0.99 
Arm DXA 
Fat-N 
7 20.68 0.00 
Arm DXA 
Fat-A 
12 41.13 5 E-6 
Upper Arm 
Skinfold-N 
36 153 0.00 
Upper Arm 
Skinfold-A 
19 6114 0.00 
Upper Arm 
Skinfold-HD 
21 35032 0.00 







Table 6.2.1-5.  Beta values and probability of fit for TBK (± SD of 5%) 
versus standard body composition indices. 
 
TBK Versus  n Beta Probability 
 ICW-N 7 7.63 0.21 
ICW-A 11 32.08 0.00 








12 0.02 1.00 
Upper Arm 
Skinfold-HD 
21 8450 0.00 







Table 6.2.1-6.  Beta values and probability of fit for PBK versus  
TBK (± SD of 5%). 
 
PBK Versus  n Beta Probability 
TBK-Na 10 0.57 0.99 
TBK-Ab 13 0.74 0.99 
TBK-HDc 21 2.43 0.99 







6.2.2 Discussion of Clinical Significance of Analytical Results 
 
PBK versus TBK 
 
The strongest correlation between PBK with TBK was observed for the 
normal cohort, with weaker correlations for the aging and HD cohorts, with r2 
values of 0.72, 0.52, and 0.51, respectively (Figs. 6.2.2-1 to 6.2.2-3).  (Cohorts of 
PBK with TBK were plotted separately for clarity.)  The high correlation in the 
normal cohort corroborates that the PBK and TBK are related measures.  The 
greater scatter in the data for the PBK as compared with TBK could indicate the 
variability of arm size to a given value of TBK.  Another possibility is the self-
shielding of PBK by arm fat which would decrease the values of PBK for larger 
subjects.  Additional regional K calibrations are necessary to explain the 
differences in the relationship of PBK to TBK.  However, the confirmation of the 
linear relationship between PBK and TBK by the beta statistics test, suggests that 
the relationship is highly linear, and therefore, a possible new hypothesis is that 
PBK may be used as an alternative measure to TBK.  With more specific regional 
K calibrations performed, the precision and accuracy of PBK can be further 
refined, and the differences between PBK and TBK identified and a curve-fit 


























Normal Normal (BMI over 30) Regression (Normal)
r2 = 0.72 


























r2 = 0.52 
























HD HD (BMI over 30) Regression (HD)
r2 = 0.51 





PBK versus ICW 
 
A strong linear regression correlation was found for PBK versus ICW for 
the normal cohort, with an r2 value of 0.85 (Fig. 6.2.2-4).  This strong correlation 
was in concordance with a very high correlation of TBK versus ICW with r2 value 
of 0.97 (Fig. 6.2.2-5).  As previously mentioned in Eq. 1-5, the established 
relationship of TBK with ICW is 97%.  Thus, the high correlation of the normal 
cohort of TBK with ICW reflects this relationship, and suggests that the 
relationship of the normal cohort of PBK with ICW is similar.  However, this 
linearity was not confirmed through the beta statistics test.  The conclusion in this 
case therefore, is that there is a strong relationship between PBK versus ICW and, 
as predicted, a strong relationship between TBK versus ICW, however, the two 
relationships are not linear, and other statistical or clinical factors are involved in 



























HD Normal (BMI over 30)
HD (BMI over 30) Regression (Normal)
Regression (Aging) Regression (HD)
N: r2 = 0.85   A: r2 = 0.45   HD: r2 = 0.27   
























HD Normal (BMI over 30)
HD (BMI over 30) Regression (Normal)
Regression (Aging) Regression (HD)
N: r2 = 0.97   A: r2 = 0.84   HD: r2 = 0.60    





PBK versus Arm DXA Lean Soft Tissue  
 
Another strong linear regression correlation was indicated for PBK versus 
arm DXA lean soft tissue, for both the normal and aging cohorts, with a r2 value 
of 0.71 and 0.72, respectively (Fig. 6.2.2-6).  This correlation was also in 
concordance with the very high correlations of TBK versus arm DXA lean soft 
tissue for the normal and aging cohorts, with r2 values of 0.94 and 0.97, 
respectively (Fig. 6.2.2-7).  The larger data spread present in the PBK plots than 
in the TBK plots is possibly explained by the reduced signal intensity from the 
isolated arm.  Since the index of comparison, arm DXA lean soft tissue, is an 
extrapolative measure (from whole body DXA) of primarily arm muscle (with 
some connective tissue), the strongest linear correlation would be expected to be 
with an arm measure of K, than with the whole body measure of K.  Since TBK 
has a higher linear correlation with arm DXA lean soft tissue, than PBK, the arm 
DXA lean soft tissue extrapolation may be more indicative of whole body muscle 
mass, than of arm muscle mass.  Alternatively, the disparity may indicate the 
necessity of more precise arm PBK calibration.  The confirmation of a non- linear 
relationship for either PBK or TBK versus arm DXA lean soft tissue using the 
beta statistics test, further indicates the complexity of the relationship.  To 
conclude a clinical significance from the similarity yet disparity in the 
correlations of PBK versus arm DXA lean soft tissue and TBK versus arm DXA 
lean soft tissue, for both the normal and aging cohorts, requires further clinical 
trials of both preliminary arm measures, arm DXA extrapolation measure as well 







Figure 6.2.2-6.  Arm PBK versus arm DXA Lean Soft Tissue. 
(HD data not available.) 
 
 
N: r2 = 0.71   A: r2 = 0.72    
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Figure 6.2.2-7.  TBK versus arm DXA lean soft tissue. 
(HD data not available.) 
 
N: r2 = 0.94       A: r2 = 0.97   
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PBK versus Arm DXA Fat 
 
A strong inverse linear correlation was indicated for PBK versus arm 
DXA fat, for the normal cohort (Fig. 6.2.2-8) with an r2 value of 0.76.  This was 
consistent in trend with the weaker inverse correlation obtained from TBK versus 
arm DXA fat for the normal cohort (Figs.6.2.2-9), with an r2 value of 0.54.  The 
non-correlation of PBK versus arm DXA fat for the aging cohort (r2 = 0.048) is 
also consistent in trend with the non-correlation of TBK versus the arm DXA fat 
for the aging cohort (r2 = 0.034).  The similarity of the trends for PBK and TBK 
versus the same index suggests that K measure is inversely related to arm DXA 
fat.  The inverse linearity is greater with PBK versus arm DXA fat, than with 
TBK versus arm DXA fat, which is consistent with the inverse clinical 
relationship of fat and muscle in the extremities.71  However, since the beta 
statistics test did not confirm linearity, the relationship is at best, a rough 
correlation, and other factors are involved in the relationship.  Nevertheless, this 
trend supports the conclusion that PBK may have clinical significance and also 
may be related to arm body composition indices.  However, further clinical 







Figure 6.2.2-8.  Arm PBK versus arm DXA Fat. 
(HD data not available.) 
 
N: r2 = 0.76   A: r2 = 0.048   









0 1000 2000 3000 4000 5000















Figure 6.2.2-9.  TBK versus arm DXA fat. 
(HD data not available.) 
N: r2 = 0.54   A: r2 = 0.034   
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PBK versus Upper Arm Skinfold 
 
A weak inverse linear correlation for PBK versus upper arm skinfold was 
found for the HD cohort, with r2 value 0.62 (Fig. 6.2.2-10).  This was consistent 
in trend with the very weak inverse correlation for TBK versus upper arm 
skinfold for the HD cohort, with r2 value of 0.26 (Fig. 6.2.2-11).  Although weak 
correlations, this trend is significant, since upper arm skinfold is an alternative 
measure for whole body fat.  The stronger inverse correlation for PBK versus 
upper arm skinfold than for TBK versus upper arm skinfold, similar to the 
stronger inverse correlation of PBK versus arm DXA fat than TBK versus arm 
DXA fat, again suggests that arm PBK may inversely indicate arm fat better than 
TBK.   However, since the beta statistic did not confirm a linear relationship, 
other factors are probably involved in the relationship.   
Furthermore, the lack of correlation between PBK versus upper arm 
skinfold, for both the normal and aging cohorts, with r2 values of 0.0032 and 
0.0002, respectively, is in contrast to the stronger inverse correlation between 
PBK versus arm DXA fat, for the normal and aging cohorts, with r2 values of 0.76 
and 0.048, respectively.  Both measures (upper arm skinfold and arm DXA fat) 
are indicative of body fat (whole and arm, respectively), and therefore the 
dissimilarity of the linear correlation of PBK versus upper arm skinfold for 
normal cohort and PBK versus arm DXA fat for normal cohort suggests that arm 
PBK measure may be representing an arm muscle measure different in 
composition than a whole body muscle measure.  As an alternative, the disparity 
may be clinically explained through a discrepancy in arm DXA fat versus upper 
arm skinfold.  Nevertheless, the disparity in arm PBK correlation with the two 
independent arm and body fat measures, potentially indicates clinical significance 
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HD Normal (BMI over 30)
HD (BMI over 30) Regression (Normal)
Regression (Aging) Regression (HD)
N: r2 = 0.0032   A: r2 = 0.0002   HD: r2 = 0.62    
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HD Normal (BMI over 30)
HD (BMI over 30) Regression (Normal)
Regression (Aging) Regression (HD)
N: r2 = 0.26     A: r2 = 0.12     HD: r2 = 0.26   





Summary of Regression Analysis and Beta Statistics Analysis Results 
 
The clinical results from the linear regression analysis indicates that PBK 
does linearly correlate with some of the standard body composition indices.  
Furthermore, with the additional substantiation of the beta statistics test, both K 
measures, the preliminary PBK measure and the standard whole body TBK 
measure, were found to have a high linear correlation to each other.  This suggests 
that the arm PBK measure may be ind icative of the whole body K measure in 
conjunction with some calibration factor.  This result also indicates the validity of 
arm PBK as a measure, though the overall systematic and statistical errors 
associated with arm PBK need to be further refined subsequent to this work. 
As a final note, in all cases, linear correlations strengthened (i.e., r2 values 
increased) when obese subjects with BMI values over 30 kg/m2 were excluded.  
Therefore, all results and figures were reported with the subjects with BMI va lues 
over 30 kg/m2 systematically excluded from the linear regression analysis, since 
the majority were outliers (with the exception of Fig. 6.2.2-1).  No data in the 
aging cohort was excluded; none had BMI over 30 kg/m2.  Additional statistical 
analysis on the obese subject group could be investigated subsequently to this 






6.2.3.  Cohort Comparison Using ANOVA Analysis 
 
Preliminary comparisons of the three cohorts relative to each other, for 
PBK and TBK, were investigated using ANOVA.  The mean, standard deviation, 
and standard error of the mean (S.E.) for each cohort of PBK and TBK 
individually, are listed in Table 6.2.3-1, with the p-values for a 95% confidence 
limit shown in Table 6.2.3-2.  P-values = 0.01 are considered statistically 
significant and are indicative of statistically separate data sets. 
Comparing the three cohorts of PBK relative to each other, the normal 
versus aging cohort comparison approaches the statistically significant p-value, 
with a p-value of 0.1.  Comparing the three cohorts of TBK, relative to each other 
also approaches the statistically significant p-value with a p-value of 0.08 for the 
normal versus aging cohort comparison.  Furthermore, the low S.E. values for 
each cohort, suggest that the three cohorts may be separate data sets. 
Investigating a larger PBK data set of 142 measured PBK subjects (PBK 
was the only available measure for the additional 69 subjects), the mean value 
increased for the normal and aging PBK cohort, and decreased for the HD PBK 
cohort (Table 6.2.3-3).  Applying the ANOVA analysis to the larger PBK data set,  
the cohort comparison of normal versus HD, approaches the statistically 
significant p-value with a p-value of 0.04.  This p-value of 0.04 more strongly 
suggests that the normal and HD cohorts are separate data sets than the previous 
result since the data set was larger (Table 6.2.3-4).  The discrepancy in the results 
clearly indicates the need for large data sets to determine statistical significance 
between the cohorts, if the relationship exists.  This result needs to be further 
investigated subsequent to this work with larger sized cohort studies for all three 








Table 6.2.3-1.  Mean, standard deviation, and standard error of the mean of Normal, Aging, and Hemodialysis 
cohorts for PBK and TBK indices for n=28. 
 
 
Normal Aging Hemodialysis 
Index 













(gK) 22 3.95 ± 23 5 19 3.53 ± 22 5 28 3.83 ± 22 4 
TBK 
(gK) 







Table 6.2.3-2.  Summary of p-values at 95% C.L. from ANOVA comparisons between small PBK and TBK cohort 
data sets (n=28).  (Values approaching p<0.01 significance in italics.) 
 
 
P-values For 95% C.L. 







(gK) 0.1126 0.6230 0.2109 
TBK 






Table 6.2.3-3.  Mean, standard deviation, and standard error of the mean of Normal, Aging, and Hemodialysis 
cohorts for PBK index for n=88. 
 
 
Normal Aging Hemodialysis 
Index 





















Table 6.2.3-4.  Summary of p-values at 95% C.L. from ANOVA comparisons between larger PBK and TBK cohort 
data sets (n=88).  (Value approaching p<0.01 significance in italics.) 
 
 
P-values For 95% C.L. 
















6.2.4.  Summary of Clinical Results 
 
In summary, the initial results of statistically significant linear correlations 
of arm PBK with some standard body composition indices may indicate that PBK 
is a viable, clinically sound measure.  The additional corroboration from the beta 
statistics test on the high linearity of PBK with TBK for the three investigated 
cohorts, normal, aging, and hemodialysis, further suggests that PBK may 
represent a reasonable alternative measure of whole body K instead of the 
standard TBK measurement, subsequent to further investigations of the systematic 
and statistical errors inherent in PBK.  Additionally, with further substantiation of 
differences between cohort PBK measures, PBK may also represent an additional 
body composition measure for cohort studies.  The disparity in correlations of 
PBK versus arm and whole body measures of a same index (such as muscle (arm 
DXA lean soft tissue) and fat (arm DXA fat and upper arm skinfold) may indicate 
that in some cases, PBK may be an alternative measure for organ specific studies.  
An area which could be addressed in future studies, is the difference in correlation 
when subjects with high BMI values are included and excluded in the statistical 
analyses.  This could be investigated further with larger sized cohorts to provide 
clinical understanding on the variation between subject data of normal and high 
BMI values.  Regardless, the preliminary statistical results potentially show PBK 








7.  Summary and Future Work 
 
This work investigated the feasibility of in vivo partial body potassium 
measure and conducted the preliminary evaluation of an in vivo measurement of 
potassium in the partial human body using gamma ray spectroscopy to measure 
naturally occurring 40K.  Prior to this investigation, partial body composition 
measures had not been undertaken, except for a limited number of investigations 
into segmental MRI and segmental DXA measure because of the inherent 
difficulties and complex constraints involved in partial body measure.  Three 
potential applications of PBK measure in the brain and in the limbs were 
investigated in connection with 1) multiple sclerosis, 2) chronic renal failure and 
sarcopenia, and 3) spinal cord injury, respectively (Chapter 1).  These three sites 
required different detector-shielding configurations and optimizations to isolate 
the K signal emitted from the organ of interest from those originating from other 
parts of the body and from the general background (Chapter 2).   
Two critically important issues in each of the systems were to maximize 
the sensitivity and to minimize the naturally occurring K background.  To 
maximize the sensitivity was important, due  to the low abundance of K in the 
organs and limited counting time for subject comfort.  Furthermore, the sensitivity 
was compromised by the ever present K background.  Sensitivity for the single 
3”x3” NaI Brain K system was demonstrated to be 59 c/g/hr and the MDL is 0.6 
gK/hr in net K counts.  With a four 5”x3” NaI Brain K system, the sensitivity was 
determined to be 452 c/g/hr and the MDL was 0.3 gK/hr in net K counts.  
Comparing the two systems, the sensitivity increased by a factor of 7.6, and the 
MDL decreased by a factor of 2.  The considerations of the sensitivity on the 
various types of detectors can be used as a guideline to constructing future PBK 
systems for other applications.   
Preliminary investigative regional phantom calibrations for each system 







PBK.  In brain PBK measure, initial calibrations of a single 3”x3” NaI Brain K 
Measuring system, suggest that K contributions from the skin, muscle, and bone 
in the cranium is minimal and the scattering effect from the cranium on K signal 
is also minimal.  In arm PBK measure, attenuation in the K signal from the arm 
by bone is not negligible, and may contribute to a reduction in K signal from 5-
15%.  Further, more in-depth calibration studies are recommended to more 
accurately correlate arm volume with arm potassium.  For example, additional 
modeling by MCNP to study the interaction of 40K with the various tissues in the 
arm (muscle, bone, skin, tendons) and the attenuation (scattering and absorption) 
of 40K within the arm prior to detection may provide a more accurate arm PBK 
value, with a smaller systematic error.   
To address the project constraint that the statistical error must be 
minimized to measure PBK more precisely so that a change in gK could be 
measured, the trapezoidal method (TM) and the library least-squares (LLS) 
method were applied to the gamma ray spectra for analysis, and evaluated for 
minimizing the statistical error.  Simulated spectra generated from measured 
single 3”x3” NaI(Tl) Brain K Measuring System spectra were used to evaluate the 
statistical error reduction, and for various cases, the LLS Method had a greater 
capacity for minimizing the statistical error, than the TM.  The LLS Method was 
also superior in resolving the K signal from room backgrounds synthetically 
created to be two- and ten-fold higher than experimentally measured.  
Furthermore, the LLS method was effective in demonstrating spectral shifts 
occurring from electronic gain shift or zero shift in its generated residuals.  These 
shifts could then be adjusted for using an iterative method (not shown) or a 
channel/energy calibration computer program (Appendix 6.3).  Because of the 
greater advantages with the LLS method, than the TM, the LLS method is 
recommended for future PBK measurement analysis.  However, for multi-detector 
systems with greater room K background measurement capacity, the TM was 







analysis method, therefore, are recommended to be taken into account when 
designing a PBK system. 
Clinical brain PBK measurements using the single 3”x3” NaI Brain K 
Measuring system, showed a discernable difference between male and female 
subjects (Chapter 6).  However, the limited cohort size of five volunteers is 
insufficient to support or refute any definitive explanation of this effect, if real.  
Further brain K studies with a larger cohort is recommended.   
Clinical arm PBK measurements using the SLR arm PBK system, for 
normal healthy adults (<62 yrs of age), normal healthy elderly adults (= 62 yrs of 
age), and adults with chronic renal failure were analyzed, and the first 
approximated arm PBK clinical values (in gK) were compared with standard body 
composition indices in the same subjects.  The most significant result, was that 
the preliminary arm PBK measures were highly correlated with TBK for all three 
cohorts.  This correlation suggests that arm PBK may be an alternative measure 
for TBK.  Furthermore, the preliminary arm PBK measures correlated strongly (r2 
= 0.7) with several body composition measures that TBK measures also correlated 
strongly with, including intracellular water (ICW) in the normal cohort, and arm 
DXA lean soft tissue in the normal and aging cohorts.  The high correlation of 
PBK with these body composition measures potentially indicates a possible 
relationship of arm PBK with these body composition measures.  Future work 
with larger cohort studies would confirm or refute this clinical hypothesis.  
Similarly, the weak arm PBK correlations with arm DXA fat in the normal and 
aging cohorts, and upper arm skinfold in HD cohort that corresponded with weak 
TBK correlations compared with the same body composition indices, may also 
have clinical significance when compared using larger cohort studies.  
Using ANOVA analysis to compare the three cohort data sets of arm PBK 
measures for 142 subjects, at the 95% confidence level, the p-value of 0.04 
suggests that the normal and HD cohorts are potentially separate data sets.  This 







cohorts.  Another area for future research would be to use larger-sized cohort 
studies to clinically understand the variation between subject data of normal and 
high BMI values, since subjects with BMI’s over 30 (considered clinically obese) 
were systematically excluded in these studies, because the majority were outliers 
in the regression analysis.   
Regardless, the initial results of the high correlations of the preliminary 
arm PBK measures to standard body composition indices such as TBK and ICW 
suggests that arm PBK potentially is a viable, clinically sound measure.  From the 
high correlation of PBK with TBK, PBK may represent a reasonable alternative to 
the standard TBK measurement.  By assessing the measurable differences 
between medical cohort PBK measures, with larger sized cohort studies, with this 
substantiation, arm PBK may also represent an additional body composition 









The objective of this study into the feasibility of in vivo partial body 
potassium measure in the partial human body using gamma ray spectroscopy to 
measure the naturally occurring 40K, was to assess the ability of this technique to 
measure PBK, to define the potential areas of constraints or limitations, and to 
investigate various methods used to surmount the constraints.  The main 
objectives for the three investigations in this work included: 
 
1)  Brain PBK: a.) to assess the capability of this technique to measure the low 
amounts of K present in the brain, b.) to assess the accuracy of brain K 
measure to reference values, and c.) to assess the amount of potential 
contributions of K from external sources of K to the brain K measure; 
 
2)  Arm PBK: a.) to assess the accuracy of arm PBK measure, b.) to assess the 
contributors to systematic and statistical error in arm K, and c.) to assess the 
statistical and clinical significance of PBK measure to other standard body 
composition measures; 
 
3) Leg PBK: a.) to assess the feasibility of open and mobile detector configuration 
  for leg PBK measurement. 
 
These objectives were evaluated in order to contribute to long term assessments of 
the following: 
 
1) Brain PBK: to determine the type of edema occurring in the brain through MS; 









3) Leg PBK: to determine the amount of SM loss in the body during the acute 
stage of SCI.   
 
Overall Assessment of PBK  
 
In general, from simulation and clinical measurement, it appears that PBK 
is measurable using gamma ray spectroscopy, regardless of amount.  Second, 
through the analytical methods investigated in this work, the statistical error in the 
measurement can be reduced to acceptable levels for meaningful values of PBK.  
Third, the systematic error contribution to overall PBK value from the calibration 
using phantoms appears to be small to minimal, since the systematic errors in 
phantom construction is 1-2%.  However, the error between phantom measure and 
whole body potassium measure as corroborated by 42K dilution method and by 
cadaver study indicate that there may be a further variability of 3.5% (coefficient 
of variance) between true K value and phantom measured K.6,18  Finally, more in-
depth calibrations are needed to assess contributions of spurious, non-related K 
surrounding the organ of interest, and the effects of non-related tissues on PBK 
detection.   
 




As a first approximation of the amount of K in the brain using gamma ray 
spectroscopy and compared with Reference Man, from phantom calibration and 
clinical measurement, the amount of K in the brain appears to be measurable with 
a low to moderate standard deviation for individual measurement using a basic 
3”x3” NaI(Tl) detector system.  Using this system, the ambient room background 







individual measurements of 5% and the standard error in the mean for multiple 
measurements over time to be 3%.  Furthermore, using this system, contributions 
from skin, muscle, and bone in the head region may contribute less than 1% of 
detectable K signal.  Cranial bone, as investigated through a Lucite® experimental 
model, may potentially scatter the K signal, while the brain tissue region, as 
modeled through a water phantom, may attenuate K signal.  Thus, more in-depth 
calibrations are recommended.  However, the clinical studies of five volunteers 
suggest that even using a limited-optimized detection system, brain PBK was 
measurable.   
Initial assessments with the single 3”x3” NaI(Tl) detection system with its 
limited-optimized shielding, through simulations and clinical measurements, 
suggests that brain PBK measurements with this basic system have ±5%-9% 
statistical error and therefore is 91%-95% accurate in measuring brain PBK.  A 
more optimized system, such as the prototype four 5”x3” NaI(Tl) detection 
system, with more detectors, but without shielding, suggests that brain PBK is 
measurable with a ± 4% statistical error.  Clearly, both optimized shielding and 
number of detectors will be important to reducing the statistical error to a level in 




Through multiple repeated phantom measurements, calibrations, and a 
significant number of clinical measurements, it appears that for the SLR Arm K 
system, the amount of K in the arm is measurable and meaningful, with a low 
standard deviation for individual measurement (3-4%).  Phantom measurements 
are highly reproducible with a standard deviation in the individual measurements 
of 1%,  and a standard error in the mean of the population of 0.2% for a one-year 
study).  Statistical evaluation of first approximations of clinical arm PBK with 







TBK, which was corroborated through regression analysis and an applied beta 
statistics test.  Further evaluation of arm PBK with other standard body 
composition indices, indicated that arm PBK highly correlates with ICW, and 
with arm DXA lean soft tissue, and highly inversely correlates with arm DXA fat, 
with similar r2 values as TBK with the same body composition indices.  For the 
comparisons between arm PBK and these body composition indices, the high 
correlations calculated from the regression analysis and the corresponding low p-
values calculated from an applied t-test for two samples for each high correlation, 
suggest that these high correlations are statistically valid.  These correlations have 
potential clinical significance as a corroboration of the relationship of K with 




The open and mobile system envisioned for this application may be 
feasible.  Initial experimental results not included at time of publication, indicate 
that PBK may be measurable above ambient background K, however, currently is 
within the 1 s of the ambient background K.  Therefore, further optimization of 
the detector and shielding configuration design should be considered in this 










In conclusion, in vivo partial body potassium measure in the brain and arm 
using gamma ray spectroscopy have been demonstrated to be feasible with low 
systematic and statistical errors.  Furthermore, phantom measures have shown 
PBK measure to be statistically reproducible with low variations in individual 
measures and with high stability.  In addition, the initial values of clinical PBK 
calibrated with the investigated preliminary phantoms appear to have clinical 
significance.  Therefore, in conclusion, in vivo partial body potassium measure 
determination in the human body using gamma ray spectroscopy should be 
investigated further as a viable partial body composition measure and these future 
investigations will only clarify further the capability of partial body potassium 
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A.1.   LLS FORTRAN 77 Program 
(Modified with permission from Wielopolski L.  Previously unpublished 
program.  1976.77) 
 
!     P R O G R A M   L A H E Y _ L L S 
! 
!     L I B R A R Y    L E A S T   S Q U A R E   A N A L Y S I S 
! 
!     PURPOSE: 
!          GAMMA SPECTRUM DECONVOLUTION USING LIBRARY LEAST 
!          SQUARE  ANALYSIS  
! 
!     INPUT: 
!          N = TOTAL NUMBER OF CHANNELS 
!          M = NUMBER OF LIBRARIES TO BE USED 
!          STDNAME = NAME OF THE STANDARD LIBRARY TO BE USED 
!          STITLE = NAME OF THE LIBRARIES AVAILABLE 
!          K = NUMBER OF ARRAY ASSOCIATED WITH LIBRARY NAME 
!               (1 TO M) 
!          I = NUMBER OF ARRAY ASSOCIATED WITH NUMBER OF 
!               CHANNELS (1 TO N) 
!          CH(K,I) = CHANNEL NUMBER I FOR LIBRARY K 
!          ST(K,I) = VALUE OF THE LIBRARY (K) IN CHANNEL I 
!          CHY(K,I) = CHANNEL NUMBER I IN THE MEASURED SPECTRA 
!          Y(I) = VALUE OF THE MEASURED SPECTRUM IN CHANNEL I 
!          NSTART = START ANALYSIS AT CHANNEL NSTART + 1 
!          YY(I) = Y(I + NSTART) 
!          SS = PROMPT FOR MORE DATA, IF 'Y', PROGRAM EXECUTES 
!               AGAIN AND OVERWRITES PREVIOUS RESULTS--USE TO 
!               CHANGE NSTART 
! 
!     OUTPUT:     
!          X(STANDARD (M)) = LIBRARY INTENSITY 
!          SD(M) = STANDARD DEVIATION 
!          CHI = CHI-SQUARED 
!          ZR(I) = RELATIVE RESIDUALS = (B(I) - ASUM) / SQRT(B(I)); 








!     SUBROUTINES: 
!          1.  SUBROUTINE LAHEY_LSQ(ST,YY,ZR,M,N,STITLE)  =  
!               CALCULATES LEAST SQUARED ANALYSIS 
!          2.  SUBROUTINE  LAHEY_MINV2(AI,AINV,M,D) = CALCULATES 
!               INVERSE MATRIX AINV FROM MATRIX AI 
! 
!     COMMENTS: 
!          1.  LIBRARIES AND MEASURED SPECTRUM MUST NOT 
!               CONTAIN ZEROS 
!          2.  N (TOTAL NUMBER OF CHANNEL NUMBERS) MUST BE 
!               SAME FOR ALL SPECTRA & LIBRARIES 
!          3.  LIBRARY NAME MUST BE SPECIFIED IN SAME ORDER AS 




      PROGRAM LAHEY_LLS 
      CHARACTER STDNAME*4,STITLE(10) *4 
      CHARACTER *1 SS 
      REAL ST(10,512),YY(512),ZR(512),Y(512),CH(10,512),CHY(512) 
      OPEN (2,FILE='UNK.ASC',ERR=90) 
      OPEN (3,FILE='TSTDKBS.ASC',ERR=92) 
!     FILE 2--MEASURED GAMMA SPECTRUM 
!     FILE 3--LIBRARY STANDARDS SPECTRA: BACKGROUND AND K 
  25  WRITE (*,*) 'ENTER TOTAL NUMBER OF CH. # (MAX = 1 to 512): ' 
      READ (*,320) N 
 320  FORMAT (I4) 
      WRITE (*,19) N 
  19  FORMAT (2X,'N= ',I4) 
      K=0 
      WRITE (*,*) 'NUMBER OF STANDARDS USED (MAX = 10): ' 
      READ (*,340) M 
 340  FORMAT (I2) 
      WRITE (*,21) M 
  21  FORMAT (2X,'M= ',I2) 
!     IF LOOP TO READ STANDARDS FILE AND DETERMINE LIBRARIES 
!     TO USE 
  35  K=K+1 
      WRITE (*,*) 'NAME OF STANDARD (BCKG,K,ETC. UP TO 4 CHAR. 
      LONG): ' 
      READ (*,330) STDNAME 
 330  FORMAT (A4,/) 







  23  FORMAT (2X,'STDNAME= ',A4) 
 360  FORMAT (A4,/) 
  40  READ (3,360,IOSTAT=IRR,ERR=95,END=10) STITLE(K) 
      READ (3,101,IOSTAT=IRR,ERR=95,END=10) (CH(K,I),ST(K,I),I=1,N) 
      WRITE (*,*) STITLE(K) 
      PAUSE 
      WRITE (*,13) (CH(K,I),ST(K,I),I=1,N) 
  13  FORMAT (2X,F8.0,F8.0) 
      PAUSE 
      IF ((STDNAME .EQ. STITLE(K)) .AND. (K .LT. M)) GOTO 35 
      IF (STDNAME .NE. STITLE(K)) GOTO 40 
  38  CONTINUE 
!     IF LOOP ENDS AND MEASURED GAMMA SPECTRA READ 
  15  READ (2,201,IOSTAT=IRR,ERR=100,END=20) (CHY(I),Y(I),I=1,N) 
      WRITE (*,17) (CHY(I),Y(I),I=1,N) 
  17  FORMAT (2X,F10.0,F14.5) 
      PAUSE 
 101  FORMAT (F10.0,F10.0) 
 201  FORMAT (F10.0,F16.7) 
  20  WRITE (*,*) 'START LSQ AFTER WHAT CH # ? (TYPE 0 FOR CH. 1) ' 
      READ (*,410) NSTART 
 410  FORMAT (I3) 
!     RE-ASSIGNS LIBRARY AND MEASURED SPECTRA TO BEGIN AT 
!     (I+NSTART) FOR LEAST SQUARES ANALYSIS 
      N=N-NSTART 
      DO 1 I=1,N 
      DO 2 K=1,M 
   2  ST(K,I)=ST(K,I+NSTART) 
      YY(I)=Y(I+NSTART) 
   1  ZR(I)=0.0 
!     SUBROUTINE LSQ (LEAST SQUARE) CALLED 
      CALL LAHEY_LSQ(ST,YY,ZR,M,N,STITLE) 
!     PROMPT FOR MORE DATA 
      WRITE (*,*) 'MORE DATA?  (Y OR N): ' 
      READ (*,140) SS 
 140  FORMAT (A1) 
      IF (SS .EQ. 'Y') GOTO 25 
  80  STOP 
!     WRITE STATEMENT FOR ERRORS IN READING FILE 2 
  90  WRITE (*,*) 'OPEN FILE ERROR (FILE 2)' 
      PAUSE 
      STOP 







  92  WRITE (*,*) 'OPEN FILE ERROR (FILE 3)' 
      PAUSE 
      STOP 
!     WRITE STATEMENT FOR ERRORS IN READING FILE 3 
  95  WRITE (*,110) IRR 
 110  FORMAT (1X,'ERROR IN READING STANDARD',I3) 
      PAUSE 
      STOP 
!     WRITE STATEMENT FOR ERROR IN FILE 3, FINDING END OF FILE 
!     BEFORE REACHING END OF CHANNEL NUMBER SPECIFIED 
  10  WRITE (*,*) 'FOUND END OF UNIT FILE 3 (STANDARDS)' 
      PAUSE 
      GOTO 38 
!     WRITE STATEMENT FOR ERROR IN READING FILE 2 
 100  WRITE (*,115) IRR 
 115  FORMAT (1X,'ERROR IN READING UNKNOWN DATA',I3) 
      PAUSE 
      STOP 
      END 
 
      subroutine lahey_lsq(ST,YY,ZR,M,N,STITLE) 
      CHARACTER*4 STITLE(10) 
      REAL ST(10,512),YY(512),ZR(512) 
      DIMENSION SD(10),AI(10,10),AINV(10,10),A(512,10),B(512),Y(10) 
      DIMENSION Z(512),X(512) 
      OPEN (4,FILE='RESULT1',STATUS='NEW') 
      OPEN (7,FILE='RESULT2',STATUS='NEW') 
!     FILE 4--SELECTED LIBRARIES LISTED AS OUTPUT 
!     FILE 7--LISTS X(LIBRARY) WITH SD, RELATIVE RESIDUALS, AND 
!     UNKNOWN DATA SET 
      DO 400 I = 1,N 
      B(I) = YY(I) 
      DO 400 J = 1,M 
      A(I,J) = ST(J,I) 
 400  CONTINUE 
!     DO LOOP CALCULATES DETERMINANT (CSUM) & TRANSFORMS 
!     INTO NEW MATRIX AI(M,M) WITH THE DIMENSIONS (M) OF THE 
!     NUMBER OF STANDARDS 
      DO 550 K =1,M 
      DO 550 J = 1,M 
      CSUM = 0.0 
      DO 500 I = 1,N 







      AI(K,J) = CSUM 
 550  CONTINUE 
!     DO LOOP CALCULATES Y(L) 
      DO 600 L =1,M 
      YSUM = 0.0 
      DO 575 I = 1,N 
 575  YSUM = YSUM + A(I,L) 
      Y(L) = YSUM 
 600  CONTINUE 
!     SUBROUTINE MINV2 CALLED 
!     CALCULATES VECTOR AINV OF VECTOR AI 
      CALL LAHEY_MINV2(AI,AINV,M,D) 
!     DO LOOP CALCULATES X(I) 
      DO 800 I = 1,M 
      XSUM = 0.0 
      DO 700 J = 1,M 
 700  XSUM = XSUM + Y(J) * AINV(I,J) 
      X(I) = XSUM 
 800  CONTINUE 
!     DO LOOP CALCULATES ASUM, Z(I), AND 
!     RELATIVE RESIDUALS ZR(I) 
      DO 902 I = 1,N 
      ASUM = 0.0 
      DO 901 J = 1,M 
 901  ASUM = ASUM + A(I,J) * X(J) 
      Z(I) = B(I) - ASUM 
 902  ZR(I) = Z(I)/SQRT(B(I)) 
      R = 0.0 
      CHI = 0.0 
      AN = N 
      AM = M 
!     DO LOOP CALCULATES R 
      DO 903 I = 1,N 
      R = R + ZR(I)**2 
!     CHI CALCULATION 
      IF(B(I) .NE. 0.0)THEN 
      CHI = CHI + Z(I) * Z(I)/(ABS(B(I)) * (AN - AM)) 
      ELSE 
      ENDIF 
 903  CONTINUE 
!     DO LOOP CALCULATES STANDARD DEVIATION (SD(M)) 
      DO 904 J = 1,M 







      WRITE (4,1) (J,X(J),SD(J),J=1,M) 
      WRITE (4,2) CHI 
      WRITE (4,12) 
      WRITE (4,5) (ZR(L),L=1,N) 
      WRITE (4,3) (B(I),I = 1,N) 
   1  FORMAT(//,5X,'STD #: ',I2,2X,'X(I)=',F15.5,5X,'SD(I)=',F15.5) 
   2  FORMAT(//,9X,'CHI=',F20.5,//) 
  12  FORMAT(/,10X,'RELATIVE RESIDUALS ',//) 
   5  FORMAT (2X,F18.10,2X,F18.10,2X,F18.10,2X,F18.10) 
   3  FORMAT(//,10X,'UNKNOWN SPECTRA DATA ',//(6F8.1)) 
      WRITE (7,6) 
   6  FORMAT (//,5X,'STANDARDS SPECTRA',/) 
      DO 905 K = 1,M 
      WRITE (7,7) STITLE(K) 
   7  FORMAT (/,A4,/) 
      WRITE (7,8) (ST(K,I),I=1,N) 
   8  FORMAT(6F8.1) 
 905  CONTINUE 
      CLOSE (4, STATUS='KEEP') 
      CLOSE (7, STATUS='KEEP') 
      RETURN 
      END 
 
      subroutine lahey_minv2 (A,AINV,M,DET) 
!     MODIFIED FROM _FORTRAN 77 2ND ED_, BORSE G.J.,  
!     PWS-KENT: BOSTON (1997), 468. 
! 
!     VECTOR AI IN PROGRAM LLS IS VECTOR A IN SUBROUTINE 
!     MINV2 
      INTEGER M,IP 
      REAL A(10,10),AINV(10,10),DET,FACTOR 
      DET = 1.0 
      DO 1 I = 1,M 
      DO 1 J = 1,M 
      IF(I .EQ. J)THEN 
           AINV(I,J) = 1.0 
      ELSEIF (I .NE. J) THEN 
           AINV(I,J) = 0.0 
      ENDIF 
   1  CONTINUE 
      DO 7 IP = 1,M 
           IMXV = IP 







      IF(ABS (A(IR,IP)) .GT. ABS (A(IMXV,IP)))THEN 
           IMXV = IR 
      ENDIF 
   2  CONTINUE 
      IF(IMXV .NE. IP)THEN 
      DO 3 IC = 1,M 
           TEMP = AINV(IP,IC) 
           AINV(IP,IC) = AINV(IMXV,IC) 
           AINV(IMXV,IC) = TEMP 
           IF(IC .GE. IP)THEN 
                TEMP = A(IP,IC) 
                A(IP,IC) = A(IMXV,IC) 
                A(IMXV,IC) = TEMP 
           ENDIF 
   3  CONTINUE 
      ENDIF 
      PIVOT = A(IP,IP) 
      DET = DET*PIVOT 
      IF(DET .EQ. 0.0)THEN 
      WRITE (*,*) 'FATAL ERROR IN MINV2--ZERO DET, MATRIX 
      SINGULAR' 
      PAUSE 
      RETURN 
      ENDIF 
      DO 4 IC = 1,M 
      AINV(IP,IC) = AINV(IP,IC)/PIVOT 
      IF(IC .GE. IP)THEN 
           A(IP,IC) = A(IP,IC)/PIVOT 
      ENDIF 
   4  CONTINUE 
      DO 6 IR = 1,M 
      IF(IR .NE. IP)THEN 
           FACTOR = A(IR,IP) 
      DO 5 IC = 1,M 
            AINV(IR,IC) = AINV(IR,IC)-FACTOR*AINV(IP,IC) 
            A(IR,IC) = A(IR,IC)-FACTOR*A(IP,IC) 
   5  CONTINUE 
      ENDIF 
   6  CONTINUE 
   7  CONTINUE 
      RETURN 







A.2.  LLS Library Data Set 
(Written by L.M. Ramirez.  Created from Ambient Room Background and 
10 gK water phantom measurements.) 
 
File ‘TSTDKBS.ASC’ lists two libraries, Ambient Room Background 




1  1 
2  1 
3  1267 
4  6325 
5  9227 
6  17026 
7  12667 
8  8030 
9  6435 
10  6445 
11  6139 
12  5934 
13  5783 
14  5356 
15  5352 
16  5205 
17  5048 
18  4759 
19  4946 
20  5606 
21  5394 
22  4404 
23  3713 
24  3830 
25  3900 
26  3752 
27  3399 
28  3262 
29  3459 







31  3544 
32  2908 
33  2329 
34  2133 
35  2068 
36  1987 
37  1828 
38  1855 
39  1761 
40  1790 
41  1860 
42  1881 
43  2031 
44  2100 
45  1993 
46  1681 
47  1533 
48  1474 
49  1542 
50  1755 
51  1849 
52  1888 
53  1713 
54  1513 
55  1324 
56  1185 
57  1122 
58  1091 
59  1004 
60  950 
61  954 
62  926 
63  892 
64  942 
65  860 
66  869 
67  939 
68  853 
69  825 
70  778 
71  739 
72  755 







74  773 
75  772 
76  766 
77  843 
78  807 
79  765 
80  726 
81  767 
82  686 
83  700 
84  682 
85  606 
86  601 
87  563 
88  532 
89  538 
90  558 
91  525 
92  599 
93  591 
94  599 
95  608 
96  608 
97  528 
98  545 






















































































































































































K   
   
1  1 
2  1 
3  293 
4  1757 
5  1660 
6  328 
7  300 
8  251 
9  519 
10  520 
11  491 
12  302 
13  259 
14  503 
15  500 
16  572 
17  545 
18  662 
19  691 
20  811 
21  676 
22  559 
23  803 
24  499 
25  544 
26  511 
27  530 
28  654 
29  655 







31  529 
32  366 
33  445 
34  489 
35  465 
36  420 
37  502 
38  437 
39  463 
40  439 
41  460 
42  482 
43  508 
44  377 
45  394 
46  369 
47  327 
48  375 
49  356 
50  272 
51  304 
52  268 
53  346 
54  310 
55  372 
56  356 
57  370 
58  286 
59  379 
60  360 
61  368 
62  361 
63  427 
64  333 
65  387 
66  391 
67  297 
68  316 
69  314 
70  333 
71  347 
72  332 







74  364 
75  373 
76  353 
77  361 
78  389 
79  362 
80  428 
81  413 
82  459 
83  441 
84  378 
85  387 
86  444 
87  401 
88  381 
89  405 
90  359 
91  480 
92  449 
93  445 
94  414 
95  469 
96  406 
97  469 
98  449 





























































































































































































A.3.  Gain and Zero Shift FORTRAN 77 Program 
(Written by L.M. Ramirez) 
 
!     P R O G R A M   L A H E Y _ S H I F T 
! 
!     G A I N  A N D  Z E R O  S H I F T  A D J U S T M E N T 
! 
!     PURPOSE: 
!          ADJUSTING OF GAIN SHIFT AND ZERO SHIFT IN A MEASURED 
!          SPECTRUM TO A STANDARD 
! 
!     INPUT: 
!          J = START SHIFT CORRECTION AT CHANNEL J 
!          N = TOTAL NUMBER OF CHANNELS IN MEASURED SPECTRUM 
!          I = NUMBER OF ARRAY ASSOCIATED WITH NUMBER OF 
!                CHANNELS (1 TO N) 
!          CHY(I) = CHANNEL NUMBER I IN THE MEASURED SPECTRUM 
!          S(I) = VALUE OF THE MEASURED SPECTRUM IN CHANNEL I 
!          ZSTD = STANDARD ZERO CHANNEL SETTING 
!          ZSHIFT = ZERO CHANNEL OF MEASURED SPECTRUM 
!          FSTD = STANDARD FINE GAIN SETTING 
!          FSHIFT = FINE GAIN SETTING OF MEASURED SPECTRUM TO 
!                           STANDARD SPECTRUM SETTINGS 
! 
!     OUTPUT: 
!          F = RATIO OF FSHIFT/FSTD 
!          K = CHANNELS OF NEW CORRECTED SPECTRUM FROM J TO 270 
!          FB(K) = NEW Y VALUE AT CHANNEL NUMBERS OF NEW 
!                         CORRECTED SPECTRUM 
! 
!     SUBROUTINES: 
!          1.  SUBROUTINE LAHEY_CALC(J,CHY,S,ZSTD,ZSHIFT,F) =  
!               CREATES A NEW SPECTRUM FILE WITH GAIN SHIFT AND/OR 
!               ZERO CHANNEL CORRECTED 
! 
!     COMMENTS: 
!          1.   IF NO ZERO SHIFT, ENTER SAME VALUE FOR ZSTD AND 
!                ZSHIFT 
!          2.   FSHIFT REQUIRES SAME DAY CALIBRATION OF SYSTEM 
!          3.   PROGRAM ASSUMES TOTAL CHANNELS OF MEASURED 







!          4.   GAIN SHIFT CORRECTION--USES LINEAR INTERPOLATION 
!               TO CALCULATE Y VALUE OF FRACTION CHANNEL BASED 
!               ON THE LINE GENERATED BETWEEN TWO POINTS—WHOLE 
!               NUMBER CHANNEL ABOVE AND BELOW FRACTIONAL 
!               CHANNEL NUMBER 
!          5.  CHANNEL NUMBER OF STANDARD SPECTRA EQUIVALENT 
!               TO FRACTIONAL CHANNEL NO. IN SHIFTED SPECTRA 
!          6.  ZERO SHIFT CORRECTION--CALCULATED BY RE-ITERATING 
!               VALUES AT SPECIFIED CHANNEL NUMBER 
! 
      PROGRAM LAHEY_SHIFT 
      REAL CHY(300),S(300),ZSTD,ZSHIFT,FSTD,FSHIFT,F 
      INTEGER J,N 
      OPEN (2,FILE='UNK.ASC',ERR=90) 
      OPEN (4,FILE='UOUTPUT.ASC',STATUS='NEW') 
!     FILE 2--MEASURED SPECTRA 
!     FILE 4--OUTPUT FILE LISTS INPUT PARAMETERS AND FILE 2  
      WRITE (*,*)'ENTER FIRST CH. NO. OF SPECTRA REGION TO BE 
      FIXED: ' 
      READ (*,100) J 
 100  FORMAT (I4) 
      WRITE (4,105) J 
 105  FORMAT (2X,'J = ',I4) 
      WRITE (*,*) 'ENTER TOTAL NUMBER OF CH. # (MAX=1 to 300): ' 
      READ (*,120) N 
 120  FORMAT (I4) 
      WRITE (4,125) N 
 125  FORMAT (2X,'N = ',I4) 
!     STATEMENT READS FILE 2 AND WRITES TO FILE 4 
      READ (2,130,IOSTAT=IRR,ERR=95,END=135) (CHY(I),S(I),I=1,N) 
 130  FORMAT (F10.0,F10.0) 
      WRITE (*,132) (CHY(I),S(I),I=1,N) 
 132  FORMAT (2X,F8.0,F8.0) 
      WRITE (4,*) '  CHY(I)   S(I)' 
      WRITE (4,134) (CHY(I),S(I),I=1,N) 
 134  FORMAT (2X,F8.0,F8.0) 
!     STATEMENTS READ PARAMETERS FOR ZERO SHIFT 
 135  WRITE (*,*) 'ENTER STANDARD ZERO CHANNEL SETTING: ' 
      READ (*,140) ZSTD 
 140  FORMAT (F5.0) 
      WRITE (4,145) ZSTD 
 145  FORMAT (2X,'ZSTD = ',F5.0) 







      READ (*,150) ZSHIFT 
 150  FORMAT (F5.0) 
      WRITE (4,155) ZSHIFT 
 155  FORMAT (2X,'ZSHIFT = ',F5.0) 
!     STATEMENTS READ PARAMETERS FOR GAIN SHIFT 
!     USES VALUES FROM FINE GAIN ON AMPLIFIER 
      WRITE (*,*) 'ENTER FINE GAIN OF STANDARD SETTING (W/ 
      DECIMAL): ' 
      READ (*,160) FSTD 
 160  FORMAT (F5.2) 
      WRITE (4,165) FSTD 
 165  FORMAT (2X,'FSTD = ',F6.2) 
      WRITE (*,*) 'ENTER FINE GAIN OF SHIFTED SPECTRA (W/ 
      DECIMAL): ' 
      READ (*, 170) FSHIFT 
 170  FORMAT (F5.2) 
      WRITE (4,175) FSHIFT 
 175  FORMAT (2X,'FSHIFT = ',F6.2) 
      F=FSHIFT/FSTD 
      WRITE (4,180) F 
 180  FORMAT (2X,'F = ',F9.6) 
      CALL LAHEY_CALC(J,CHY,S,ZSTD,ZSHIFT,F) 
      CONTINUE 
  90  WRITE (*,*) 'OPEN FILE ERROR (FILE 2)' 
      PAUSE 
      STOP 
  95  WRITE (*,101) IRR 
 101  FORMAT (1X,'ERROR IN READING FILE 2',I3) 
      PAUSE 
      STOP 
      END 
 
 
      subroutine lahey_calc(J,CHY,S,ZSTD,ZSHIFT,F) 
      REAL S(300),ZSTD,ZSHIFT,F,CHY(300),S2(50) 
      REAL AK,B,A,Y,FB(300) 
      INTEGER LZSTD,LZSHIF 
      DOUBLE PRECISION AIFRAC,AQUEST 
      INTEGER J,IFRACU,IFRACD 
!     FILE 3--OUTPUT FILE OF GAIN SHIFT CORRECTED SPECTRUM 
!     FILE 7--OUTPUT FILE OF ZERO SHIFT CORRECTED SPECTRUM 
      OPEN (3,FILE='GZSHIFT.ASC',STATUS='NEW') 








!     SECTION CALCULATES ZERO SHIFT CORRECTION 
! 
!     1ST CASE, NO ZERO SHIFT PRESENT 
      IF (ZSTD .EQ. ZSHIFT) THEN 
      WRITE (7,3) 
   3  FORMAT (/,2X,'NO ZERO SHIFT CORRECTION NEEDED',/) 
      WRITE (*,*) '***NO ZERO SHIFT CORRECTION NEEDED***' 
      PAUSE 
!     2ND CASE, ZERO SHIFT PRESENT AND NO GAIN SHIFT PRESENT 
      ELSEIF (ZSTD .NE. ZSHIFT .AND. F .EQ. 1.0) THEN 
      WRITE (*,*) 'ZERO SHIFT CORRECTION NEEDED ONLY' 
      WRITE (7,4) 
   4  FORMAT (/,2X,'ZERO SHIFT CORRECTION NEEDED ONLY',/) 
           IF (ZSTD .LT. ZSHIFT) THEN 
               WRITE (*,*) 'ZERO SHIFT CORRECTION NEEDED-ZSTD LESS' 
               WRITE (7,6) 
   6           FORMAT (/,2X,'ZERO SHIFT CORRECTED SPECTRUM',/) 
               LZSHIF=ZSHIFT-1.0 
               DO 2 K=1,300 
               WRITE (7,9) CHY(K),S(K+LZSHIF) 
   9           FORMAT (2X,F5.0,F18.10) 
   2           CONTINUE 
           ELSEIF (ZSTD .GT. ZSHIFT) THEN 
               LZSTD=ZSTD 
               LZSTD=LZSTD-1 
               WRITE (*,*) 'ZERO SHIFT CORRECTION NEEDED-ZSTD 
               GREATER' 
               WRITE (7,5) 
   5           FORMAT (/,2X,'ZERO SHIFT CORRECTED SPECTRUM',/) 
               DO 11 I=1,LZSTD 
               S2(I)=1.0 
               WRITE (7,12) CHY(I),S2(I) 
  12           FORMAT (2X,F5.0,F18.10) 
  11           CONTINUE 
               LCH=300-LZSTD 
               DO 14 K=1,LCH 
               WRITE (7,13) CHY(K+LZSTD),S(K) 
  13           FORMAT (2X,F5.0,F18.10) 
  14           CONTINUE 
           END IF 
      GOTO 30 








!     SECTION CALCULATES GAIN SHIFT CORRECTION 
! 
!     AK CONVERTS K INTO REAL NUMBER 
!     AIFRAC = FRACTIONAL CHANNEL NUMBER OF NEW SPECTRA 
!                        YIELDED FROM OLD CHANNELS DIVIDED BY FINE GAIN 
!                        RATIO 
!     AQUEST = ISOLATES THE FRACTION PART OF  CHANNEL NUMBER 
!                         FROM THE WHOLE NUMBER PART 
!     B = SLOPE OF LINEAR INTERPOLATION 
!     A = INTERCEPT OF LINEAR INTERPOLATION 
!     Y = Y VALUE AT FRACTIONAL CHANNEL NUMBER BASED ON 
!            LINEAR INTERPOLATION 
!      
!     3RD CASE, ZERO SHIFT PRESENT AND GAIN SHIFT PRESENT 
      IF (ZSTD .NE. ZSHIFT .AND. F .NE. 1.0) THEN 
      WRITE (*,*) 'ZERO SHIFT AND GAIN SHIFT CORRECTION NEEDED' 
      ENDIF 
           IF (ZSTD .LT. ZSHIFT .AND. F .NE. 1.0) THEN 
           WRITE (*,*) 'ZERO SHIFT CORRECTION NEEDED-ZSTD LESS' 
           WRITE (7,7) 
   7       FORMAT (/,2X,'ZERO SHIFT & GAIN SHIFT CORRECTED 
            SPECTRUM',/) 
           ELSEIF (ZSTD .GT. ZSHIFT .AND. F .NE. 1.0) THEN 
           WRITE (*,*) 'ZERO SHIFT CORRECTION NEEDED-ZSTD GREATER' 
           WRITE (7,8) 
   8       FORMAT (/,2X,'ZERO SHIFT & GAIN SHIFT CORRECTED 
            SPECTRUM',/) 
           ENDIF 
! 
      IF (F .NE. 1.0) THEN 
      DO 10 K = J, 300 
      AK=K 
      AIFRAC=AK/F 
!     "IF" STATEMENTS EVALUATE IF THE FRACTION IS GREATER OR 
!     LESS THAN 0.5 TO FIND VALUE OF S(K) ABOVE AND BELOW 
!     FRACTION (MIXED MODE INTENTIONAL, CONVERTS TO REAL) 
      AQUEST=AIFRAC-(AK-1.0) 
           IF (AQUEST .GT. 0.5) THEN 
           IFRACU=AIFRAC+0.5 
           IFRACD=IFRACU-1 
           ELSEIF (AQUEST .LT. 0.5) THEN 







           IFRACU=IFRACD+1 
           ELSEIF (AQUEST .EQ. 0.0) THEN 
           WRITE (*,*) K, AIFRAC 
           PAUSE 
           ENDIF 
!     CALCULATES THE NEW MEASURED SPECTRUM IN STANDARD 
!     CHANNEL NUMBERS 
      B= (S(IFRACU) - S(IFRACD))/(IFRACU-IFRACD) 
      A= S(IFRACD) - (B*IFRACD) 
      Y= A + (B*AIFRAC) 
      FB(K)= Y / F 
           IF (ZSTD .EQ. ZSHIFT) THEN 
               WRITE (3,20) K,FB(K) 
  20           FORMAT (2X,I4,F18.10) 
           END IF 
  10  CONTINUE 
           IF (ZSTD .LT. ZSHIFT) THEN 
               LZSHIF=ZSHIFT-1.0 
               DO 18 L=J,300 
               WRITE (7,17) CHY(L),FB(L+LZSHIF) 
  17           FORMAT (2X,F5.0,F18.10) 
  18           CONTINUE 
           ELSEIF (ZSTD .GT. ZSHIFT) THEN 
               LZSTD=ZSTD 
               LZSTD=LZSTD-1 
               DO 21 I=1,LZSTD 
               S2(I)=1.0 
               WRITE (7,22) CHY(I),S2(I) 
  22           FORMAT (2X,F5.0,F18.10) 
  21           CONTINUE 
               LCH=300-LZSTD 
               DO 24 L=1,LCH 
               WRITE (7,23) CHY(L+LZSTD),FB(L) 
  23           FORMAT (2X,F5.0,F18.10) 
  24           CONTINUE 
           ENDIF 
      WRITE (*,*) 'GAIN SHIFT CORRECTION COMPLETED' 
      ENDIF 
  30  RETURN 
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